2006-Endocrinology-The Mouse Testis Is the Source of Various Serine Proteases and Serine Proteinase
诺贝尔奖-细胞分子生物学相关领域的

细胞分子生物学相关领域的诺贝尔奖2000 M&P 神经系统的信号转导2001 M&P 发现细胞周期的关键调控因子2002 Chemistry 质谱法测定生物大分子核磁共振法测定生物大分子在溶液中的结构M&P 器官发育的遗传基础和细胞的程序化死亡2003 Chemistry 发现水通道离子通道的结构和功能2004 M&P发现气味分子受体和嗅觉系统的组成Chemistry 发现泛素介导的蛋白质降解途径2005 M&P 发现幽门螺杆菌及其在胃肠道疾病中的作用2006 Chemistry真核生物转录的分子基础M&P RNA干扰——双螺旋RNA能够沉默基因表达2007 M&P 基因靶向技术2008 Chemistry 绿色荧光蛋白M&P 艾滋病毒人乳头状瘤病毒致宫颈癌2009 M&P 染色体端粒酶Chemistry 核糖体的机构和功能2010年诺贝尔奖奖项得主化学奖得主10月6日,2010年诺贝尔化学奖授予美国科学家理查德-海克、根岸英一和日本科学家铃木彰,因开发更有效的连接碳原子以构建复杂分子的方法获奖。
瑞典皇家科学院诺贝尔颁奖委员会在颁奖状中称,钯催化的交叉偶联是今天的化学家所拥有的最为先进的工具。
这种化学工具极大地提高了化学家们创造先进化学物质的可能性,例如,创造和自然本身一样复杂程度的碳基分子。
碳基(有机)化学是生命的基础,它是无数令人惊叹的自然现象的原因:花朵的颜色、蛇的毒性、诸如青霉素这样的能杀死细菌的物质。
有机化学使人们能够模仿大自然的化学,利用碳能力来为能发挥作用的分子提供一个稳定的框架,这使人类获得了新的药物和诸如塑料这样的革命性材料。
为了创造这些复杂的化学物质,化学家需要能够将碳原子联接在一起。
不过,碳是稳定的,碳原子之间并不能够轻易发生反应。
因此,科学家们将碳原子联系在一起的首批方法就是基于使碳更为活跃的技术。
这样的方法在创造简单的分子时起到了效果,但是在对更为复杂的分子进行合成时,科学家们在他们的试管里发现了太多并不需要的副产品。
分子生物学 考博真题

中国疾控中心2005年分子生物学(博士)一、名词解释1.EST2.YAC3.Sense DNA4.RNAi5.Race二、问答题1、乳糖操纵子的结构。
IPTG如何诱导结构基因表达?2、正向突变、抑制突变及回复突变的定义及与突变的关系。
3、PUC18克隆载体的结构特征。
4、在做PCR过程中,常遇到的问题及解决方法。
5、已知蛋白A、B之间相互作用,C、D分别与A、B 相似,如何签定C、D之间的相互作用,两种方法说明之。
6、试用分子生物学相关知识建立动物模型的方法,如何建立病原生物学的动物模型。
军事医学科学院1995年分子生物学试题(博士)1. Apoptosis的生物学意义及其调控基因。
2.基因转移的概念及基因转移载体应具备的条件。
3.原癌基因的功能及其转化为癌基因的机理。
4.人主要组织相容性抗原在细胞识别中的作用及原理。
5.染色体重排对生物体的影响及其主要类型。
6.噬菌体显示技术原理及其在生物学研究中的意义。
军事医学科学院1996年分子生物学试题(博士)1.什么是原癌基因?它们怎样被反转录病毒激活?2.什么是tumor supperssor gene?举例说明它的调控功能。
3.细胞染色体的异常如何导致癌基因的激活?4 解释以下名词:(1) gene knock-out (2) molecular hybridization (3) restriction fragment length polymorphism (4) human genome project5.G蛋白的结构特点信其功能.6 .apoptosis的特征与其生理及病理意义,已知它的调控基因有哪些?2006 协和生物化学与分子生物学专业博士试题一、填空(24空24分)1.---------年,由-------和-------(英文姓)首次提出了DNA的双螺旋模型,其结果发表在----杂志,他们提出的实验依据是-------和--------。
染色体和性发育异常疾病

对人类性腺发育的主要知识,来源于对X 和Y 染色体的认识。
最核心的原则是,Y 染色体(主要是Y 染色体上的SRY 基因)决定睾丸的形成和发育。
睾丸产生雄激素,促进阴茎增大、肌肉发达和其他男性化表现。
而XX 染色体,决定卵巢的形成。
卵巢产生大量雌激素,促进乳房发育和其他女性第二性征表现。
当染色体性别(XY 或XX)、性腺性别(卵巢或睾丸)、内生殖器性别(前列腺、输卵管、子宫)和外生殖器性别(阴茎、尿道开口位置、阴蒂、阴道开口位置)表现不一致,称为“性发育异常疾病”。
临床中对性分化异常疾病的鉴别诊断,常从以上四个层面进行分析[1]。
性发育异常疾病的诊断非常困难,约50%患者得不到确诊。
近10年研究发现,很多性腺发育相关基因(如DAX-1、DMRT1、SOX-9基因[2])或者它们的启动子(SOX-9启动子)拷贝数目异常[3],会导致疾病发生。
常染色体中的很多基因,参与了性腺的形成和发育,例如SOX9、FOXL2、DMRT2基因等。
当含有这些基因的常染色体发生大片段丢失或重复时,基因表达剂量翻倍或不足,导致睾丸或卵巢发育障碍,临床表现为性发育异常[4,5]。
本文将从以下五个方面阐述染色体和性发育之间的重要联系:X 和Y 染色体的遗传学特点;特纳综合征(45,XO)的临床特点;克兰菲尔特综合征(47,XXY)的临床特点;SOX9和睾丸发育;DMRT2和性腺发育。
1 染色体X 和Y 的遗传学特点因为X 和Y 染色体包含很多与性别发育和精子生成有关的基因,因此被定名为“性染色体”。
每条性染色体有两部分组成。
靠近着丝点的大部分区域,称为“性染色体区”。
这个区域内,X 和Y 染色体各自含有不同的基因,因此两条染色体之间几乎没有遗传物质交换。
位于长臂和短臂(两个末作者简介: 茅江峰,男,副主任医师、硕士生导师。
研究方向:矮小、青春发育异常和垂体疾病。
电a i l:m a o j i a n g f e n g88@通讯作者:伍学焱,男,主任医师、教授、博士研究生导师。
HCG检测溯源问题

人绒毛膜促性腺激素检测溯源问题刘奉亭青岛兰信医学检验所,青岛266100摘要目的:探讨HCG检测的溯源性及实验间检验结果互相认可中存在的问题。
方法:结合国际国内HCG检测现状,对有关HCG检测的影响因素及国际标准物质方面的问题进行综述。
结果:HCG分子及其裂解产物种类繁多,抗原性相似又不完全相同,不同厂家试剂使用的抗体组合不同,对HCG类分子的识别不同。
一些试剂的标签不正确或不清楚,一些实验人员对HCG检验的分子种类不清楚,国内HCG收费项目不全,是导致有意无意错报检验项目的原因。
目前发布的HCG 国际标准物质含有杂质,并且对于无活性的α亚基和β亚基赋值错误。
这些都给HCG检测结果的实验室间互相认可带来困难。
结论:HCG检测的溯源及检验结果的实验室间互相认可尚存在许多问题。
要解决这些问题,需要新的、以摩尔浓度赋值的HCG国际标准的发布,各试剂厂商以新的国际标准物质作为抗原来制备抗体,并用新的抗体制备的HCG检测试剂溯源到新的国际标准。
另外,还要进一步普及有关HCG类分子及其裂解产物的知识宣传。
血清人绒毛膜促性腺激素(HCG)的测定对于妊娠的确认和监测,异位妊娠及其治疗的监测,产前筛查,先兆流产、滋养层疾病、非滋养层肿瘤、生殖细胞瘤、膀胱癌、睾丸癌、肺癌等的诊断和治疗效果的监测具有十分重要的意义[1-7]。
人绒毛膜促性腺激素(HCG)与促黄体生成激素(LH)、促卵泡激素(FSH)及促甲状腺激素(TSH)都是由一个α亚基和一个β亚基所组成[8,9] 。
这些激素都拥有共同的α亚基,它们的区别在β亚基[10]。
HCG的β亚基与FSH、TSH不同,但与LH的β亚基类似,LH的β亚基含有121个氨基酸,而HCG的β亚基含有145个氨基酸,在LH的β亚基的C末端延伸了24个氨基酸[11]。
早期,人们采用生物学方法进行妊娠实验,将尿液注入幼鼠等动物,通过观察动物的反应而判断是否怀孕。
1960年Wide和Gemzell建立了首个妊娠实验的免疫学方法――红细胞凝集法[12]。
分子生物学英文文献6

Chapter19Detection and Quantitative Analysis of Small RNAs by PCR Seungil Ro and Wei YanAbstractIncreasing lines of evidence indicate that small non-coding RNAs including miRNAs,piRNAs,rasiRNAs, 21U endo-siRNAs,and snoRNAs are involved in many critical biological processes.Functional studies of these small RNAs require a simple,sensitive,and reliable method for detecting and quantifying levels of small RNAs.Here,we describe such a method that has been widely used for the validation of cloned small RNAs and also for quantitative analyses of small RNAs in both tissues and cells.Key words:Small RNAs,miRNAs,piRNAs,expression,PCR.1.IntroductionThe past several years have witnessed the surprising discovery ofnumerous non-coding small RNAs species encoded by genomesof virtually all species(1–6),which include microRNAs(miR-NAs)(7–10),piwi-interacting RNAs(piRNAs)(11–14),repeat-associated siRNAs(rasiRNAs)(15–18),21U endo-siRNAs(19),and small nucleolar RNAs(snoRNAs)(20).These small RNAsare involved in all aspects of cellular functions through direct orindirect interactions with genomic DNAs,RNAs,and proteins.Functional studies on these small RNAs are just beginning,andsome preliminaryfindings have suggested that they are involvedin regulating genome stability,epigenetic marking,transcription,translation,and protein functions(5,21–23).An easy and sensi-tive method to detect and quantify levels of these small RNAs inorgans or cells during developmental courses,or under different M.Sioud(ed.),RNA Therapeutics,Methods in Molecular Biology629,DOI10.1007/978-1-60761-657-3_19,©Springer Science+Business Media,LLC2010295296Ro and Yanphysiological and pathophysiological conditions,is essential forfunctional studies.Quantitative analyses of small RNAs appear tobe challenging because of their small sizes[∼20nucleotides(nt)for miRNAs,∼30nt for piRNAs,and60–200nt for snoRNAs].Northern blot analysis has been the standard method for detec-tion and quantitative analyses of RNAs.But it requires a relativelylarge amount of starting material(10–20μg of total RNA or>5μg of small RNA fraction).It is also a labor-intensive pro-cedure involving the use of polyacrylamide gel electrophoresis,electrotransfer,radioisotope-labeled probes,and autoradiogra-phy.We have developed a simple and reliable PCR-based methodfor detection and quantification of all types of small non-codingRNAs.In this method,small RNA fractions are isolated and polyAtails are added to the3 ends by polyadenylation(Fig.19.1).Small RNA cDNAs(srcDNAs)are then generated by reverseFig.19.1.Overview of small RNA complementary DNA(srcDNA)library construction forPCR or qPCR analysis.Small RNAs are polyadenylated using a polyA polymerase.ThepolyA-tailed RNAs are reverse-transcribed using a primer miRTQ containing oligo dTsflanked by an adaptor sequence.RNAs are removed by RNase H from the srcDNA.ThesrcDNA is ready for PCR or qPCR to be carried out using a small RNA-specific primer(srSP)and a universal reverse primer,RTQ-UNIr.Quantitative Analysis of Small RNAs297transcription using a primer consisting of adaptor sequences atthe5 end and polyT at the3 end(miRTQ).Using the srcD-NAs,non-quantitative or quantitative PCR can then be per-formed using a small RNA-specific primer and the RTQ-UNIrprimer.This method has been utilized by investigators in numer-ous studies(18,24–38).Two recent technologies,454sequenc-ing and microarray(39,40)for high-throughput analyses of miR-NAs and other small RNAs,also need an independent method forvalidation.454sequencing,the next-generation sequencing tech-nology,allows virtually exhaustive sequencing of all small RNAspecies within a small RNA library.However,each of the clonednovel small RNAs needs to be validated by examining its expres-sion in organs or in cells.Microarray assays of miRNAs have beenavailable but only known or bioinformatically predicted miR-NAs are covered.Similar to mRNA microarray analyses,the up-or down-regulation of miRNA levels under different conditionsneeds to be further validated using conventional Northern blotanalyses or PCR-based methods like the one that we are describ-ing here.2.Materials2.1.Isolation of Small RNAs, Polyadenylation,and Purification 1.mirVana miRNA Isolation Kit(Ambion).2.Phosphate-buffered saline(PBS)buffer.3.Poly(A)polymerase.4.mirVana Probe and Marker Kit(Ambion).2.2.Reverse Transcription,PCR, and Quantitative PCR 1.Superscript III First-Strand Synthesis System for RT-PCR(Invitrogen).2.miRTQ primers(Table19.1).3.AmpliTaq Gold PCR Master Mix for PCR.4.SYBR Green PCR Master Mix for qPCR.5.A miRNA-specific primer(e.g.,let-7a)and RTQ-UNIr(Table19.1).6.Agarose and100bp DNA ladder.3.Methods3.1.Isolation of Small RNAs 1.Harvest tissue(≤250mg)or cells in a1.7-mL tube with500μL of cold PBS.T a b l e 19.1O l i g o n u c l e o t i d e s u s e dN a m eS e q u e n c e (5 –3 )N o t eU s a g em i R T QC G A A T T C T A G A G C T C G A G G C A G G C G A C A T G G C T G G C T A G T T A A G C T T G G T A C C G A G C T A G T C C T T T T T T T T T T T T T T T T T T T T T T T T T V N ∗R N a s e f r e e ,H P L CR e v e r s e t r a n s c r i p t i o nR T Q -U N I r C G A A T T C T A G A G C T C G A G G C A G GR e g u l a r d e s a l t i n gP C R /q P C Rl e t -7a T G A G G T A G T A G G T T G T A T A G R e g u l a r d e s a l t i n gP C R /q P C R∗V =A ,C ,o r G ;N =A ,C ,G ,o r TQuantitative Analysis of Small RNAs299 2.Centrifuge at∼5,000rpm for2min at room temperature(RT).3.Remove PBS as much as possible.For cells,remove PBScarefully without breaking the pellet,leave∼100μL of PBS,and resuspend cells by tapping gently.4.Add300–600μL of lysis/binding buffer(10volumes pertissue mass)on ice.When you start with frozen tissue or cells,immediately add lysis/binding buffer(10volumes per tissue mass)on ice.5.Cut tissue into small pieces using scissors and grind it usinga homogenizer.For cells,skip this step.6.Vortex for40s to mix.7.Add one-tenth volume of miRNA homogenate additive onice and mix well by vortexing.8.Leave the mixture on ice for10min.For tissue,mix it every2min.9.Add an equal volume(330–660μL)of acid-phenol:chloroform.Be sure to withdraw from the bottom phase(the upper phase is an aqueous buffer).10.Mix thoroughly by inverting the tubes several times.11.Centrifuge at10,000rpm for5min at RT.12.Recover the aqueous phase carefully without disrupting thelower phase and transfer it to a fresh tube.13.Measure the volume using a scale(1g=∼1mL)andnote it.14.Add one-third volume of100%ethanol at RT to the recov-ered aqueous phase.15.Mix thoroughly by inverting the tubes several times.16.Transfer up to700μL of the mixture into afilter cartridgewithin a collection bel thefilter as total RNA.When you have>700μL of the mixture,apply it in suc-cessive application to the samefilter.17.Centrifuge at10,000rpm for15s at RT.18.Collect thefiltrate(theflow-through).Save the cartridgefor total RNA isolation(go to Step24).19.Add two-third volume of100%ethanol at RT to theflow-through.20.Mix thoroughly by inverting the tubes several times.21.Transfer up to700μL of the mixture into a newfilterbel thefilter as small RNA.When you have >700μL of thefiltrate mixture,apply it in successive appli-cation to the samefilter.300Ro and Yan22.Centrifuge at10,000rpm for15s at RT.23.Discard theflow-through and repeat until all of thefiltratemixture is passed through thefilter.Reuse the collectiontube for the following washing steps.24.Apply700μL of miRNA wash solution1(working solu-tion mixed with ethanol)to thefilter.25.Centrifuge at10,000rpm for15s at RT.26.Discard theflow-through.27.Apply500μL of miRNA wash solution2/3(working solu-tion mixed with ethanol)to thefilter.28.Centrifuge at10,000rpm for15s at RT.29.Discard theflow-through and repeat Step27.30.Centrifuge at12,000rpm for1min at RT.31.Transfer thefilter cartridge to a new collection tube.32.Apply100μL of pre-heated(95◦C)elution solution orRNase-free water to the center of thefilter and close thecap.Aliquot a desired amount of elution solution intoa1.7-mL tube and heat it on a heat block at95◦C for∼15min.Open the cap carefully because it might splashdue to pressure buildup.33.Leave thefilter tube alone for1min at RT.34.Centrifuge at12,000rpm for1min at RT.35.Measure total RNA and small RNA concentrations usingNanoDrop or another spectrophotometer.36.Store it at–80◦C until used.3.2.Polyadenylation1.Set up a reaction mixture with a total volume of50μL in a0.5-mL tube containing0.1–2μg of small RNAs,10μL of5×E-PAP buffer,5μL of25mM MnCl2,5μL of10mMATP,1μL(2U)of Escherichia coli poly(A)polymerase I,and RNase-free water(up to50μL).When you have a lowconcentration of small RNAs,increase the total volume;5×E-PAP buffer,25mM MnCl2,and10mM ATP should beincreased accordingly.2.Mix well and spin the tube briefly.3.Incubate for1h at37◦C.3.3.Purification 1.Add an equal volume(50μL)of acid-phenol:chloroformto the polyadenylation reaction mixture.When you have>50μL of the mixture,increase acid-phenol:chloroformaccordingly.2.Mix thoroughly by tapping the tube.Quantitative Analysis of Small RNAs3013.Centrifuge at10,000rpm for5min at RT.4.Recover the aqueous phase carefully without disrupting thelower phase and transfer it to a fresh tube.5.Add12volumes(600μL)of binding/washing buffer tothe aqueous phase.When you have>50μL of the aqueous phase,increase binding/washing buffer accordingly.6.Transfer up to460μL of the mixture into a purificationcartridge within a collection tube.7.Centrifuge at10,000rpm for15s at RT.8.Discard thefiltrate(theflow-through)and repeat until allof the mixture is passed through the cartridge.Reuse the collection tube.9.Apply300μL of binding/washing buffer to the cartridge.10.Centrifuge at12,000rpm for1min at RT.11.Transfer the cartridge to a new collection tube.12.Apply25μL of pre-heated(95◦C)elution solution to thecenter of thefilter and close the cap.Aliquot a desired amount of elution solution into a1.7-mL tube and heat it on a heat block at95◦C for∼15min.Open the cap care-fully because it might be splash due to pressure buildup.13.Let thefilter tube stand for1min at RT.14.Centrifuge at12,000rpm for1min at RT.15.Repeat Steps12–14with a second aliquot of25μL ofpre-heated(95◦C)elution solution.16.Measure polyadenylated(tailed)RNA concentration usingNanoDrop or another spectrophotometer.17.Store it at–80◦C until used.After polyadenylation,RNAconcentration should increase up to5–10times of the start-ing concentration.3.4.Reverse Transcription 1.Mix2μg of tailed RNAs,1μL(1μg)of miRTQ,andRNase-free water(up to21μL)in a PCR tube.2.Incubate for10min at65◦C and for5min at4◦C.3.Add1μL of10mM dNTP mix,1μL of RNaseOUT,4μLof10×RT buffer,4μL of0.1M DTT,8μL of25mM MgCl2,and1μL of SuperScript III reverse transcriptase to the mixture.When you have a low concentration of lig-ated RNAs,increase the total volume;10×RT buffer,0.1M DTT,and25mM MgCl2should be increased accordingly.4.Mix well and spin the tube briefly.5.Incubate for60min at50◦C and for5min at85◦C toinactivate the reaction.302Ro and Yan6.Add1μL of RNase H to the mixture.7.Incubate for20min at37◦C.8.Add60μL of nuclease-free water.3.5.PCR and qPCR 1.Set up a reaction mixture with a total volume of25μL ina PCR tube containing1μL of small RNA cDNAs(srcD-NAs),1μL(5pmol of a miRNA-specific primer(srSP),1μL(5pmol)of RTQ-UNIr,12.5μL of AmpliTaq GoldPCR Master Mix,and9.5μL of nuclease-free water.ForqPCR,use SYBR Green PCR Master Mix instead of Ampli-Taq Gold PCR Master Mix.2.Mix well and spin the tube briefly.3.Start PCR or qPCR with the conditions:95◦C for10minand then40cycles at95◦C for15s,at48◦C for30s and at60◦C for1min.4.Adjust annealing Tm according to the Tm of your primer5.Run2μL of the PCR or qPCR products along with a100bpDNA ladder on a2%agarose gel.∼PCR products should be∼120–200bp depending on the small RNA species(e.g.,∼120–130bp for miRNAs and piRNAs).4.Notes1.This PCR method can be used for quantitative PCR(qPCR)or semi-quantitative PCR(semi-qPCR)on small RNAs suchas miRNAs,piRNAs,snoRNAs,small interfering RNAs(siRNAs),transfer RNAs(tRNAs),and ribosomal RNAs(rRNAs)(18,24–38).2.Design miRNA-specific primers to contain only the“coresequence”since our cloning method uses two degeneratenucleotides(VN)at the3 end to make small RNA cDNAs(srcDNAs)(see let-7a,Table19.1).3.For qPCR analysis,two miRNAs and a piRNA were quan-titated using the SYBR Green PCR Master Mix(41).Cyclethreshold(Ct)is the cycle number at which thefluorescencesignal reaches the threshold level above the background.ACt value for each miRNA tested was automatically calculatedby setting the threshold level to be0.1–0.3with auto base-line.All Ct values depend on the abundance of target miR-NAs.For example,average Ct values for let-7isoforms rangefrom17to20when25ng of each srcDNA sample from themultiple tissues was used(see(41).Quantitative Analysis of Small RNAs3034.This method amplifies over a broad dynamic range up to10orders of magnitude and has excellent sensitivity capable ofdetecting as little as0.001ng of the srcDNA in qPCR assays.5.For qPCR,each small RNA-specific primer should be testedalong with a known control primer(e.g.,let-7a)for PCRefficiency.Good efficiencies range from90%to110%calcu-lated from slopes between–3.1and–3.6.6.On an agarose gel,mature miRNAs and precursor miRNAs(pre-miRNAs)can be differentiated by their size.PCR prod-ucts containing miRNAs will be∼120bp long in size whileproducts containing pre-miRNAs will be∼170bp long.However,our PCR method preferentially amplifies maturemiRNAs(see Results and Discussion in(41)).We testedour PCR method to quantify over100miRNAs,but neverdetected pre-miRNAs(18,29–31,38). AcknowledgmentsThe authors would like to thank Jonathan Cho for reading andediting the text.This work was supported by grants from theNational Institute of Health(HD048855and HD050281)toW.Y.References1.Ambros,V.(2004)The functions of animalmicroRNAs.Nature,431,350–355.2.Bartel,D.P.(2004)MicroRNAs:genomics,biogenesis,mechanism,and function.Cell, 116,281–297.3.Chang,T.C.and Mendell,J.T.(2007)Theroles of microRNAs in vertebrate physiol-ogy and human disease.Annu Rev Genomics Hum Genet.4.Kim,V.N.(2005)MicroRNA biogenesis:coordinated cropping and dicing.Nat Rev Mol Cell Biol,6,376–385.5.Kim,V.N.(2006)Small RNAs just gotbigger:Piwi-interacting RNAs(piRNAs) in mammalian testes.Genes Dev,20, 1993–1997.6.Kotaja,N.,Bhattacharyya,S.N.,Jaskiewicz,L.,Kimmins,S.,Parvinen,M.,Filipowicz, W.,and Sassone-Corsi,P.(2006)The chro-matoid body of male germ cells:similarity with processing bodies and presence of Dicer and microRNA pathway components.Proc Natl Acad Sci U S A,103,2647–2652.7.Aravin,A.A.,Lagos-Quintana,M.,Yalcin,A.,Zavolan,M.,Marks,D.,Snyder,B.,Gaaster-land,T.,Meyer,J.,and Tuschl,T.(2003) The small RNA profile during Drosophilamelanogaster development.Dev Cell,5, 337–350.8.Lee,R.C.and Ambros,V.(2001)An exten-sive class of small RNAs in Caenorhabditis ele-gans.Science,294,862–864.u,N.C.,Lim,L.P.,Weinstein, E.G.,and Bartel,D.P.(2001)An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans.Science,294, 858–862.gos-Quintana,M.,Rauhut,R.,Lendeckel,W.,and Tuschl,T.(2001)Identification of novel genes coding for small expressed RNAs.Science,294,853–858.u,N.C.,Seto,A.G.,Kim,J.,Kuramochi-Miyagawa,S.,Nakano,T.,Bartel,D.P.,and Kingston,R.E.(2006)Characterization of the piRNA complex from rat testes.Science, 313,363–367.12.Grivna,S.T.,Beyret,E.,Wang,Z.,and Lin,H.(2006)A novel class of small RNAs inmouse spermatogenic cells.Genes Dev,20, 1709–1714.13.Girard, A.,Sachidanandam,R.,Hannon,G.J.,and Carmell,M.A.(2006)A germline-specific class of small RNAs binds mammalian Piwi proteins.Nature,442,199–202.304Ro and Yan14.Aravin,A.,Gaidatzis,D.,Pfeffer,S.,Lagos-Quintana,M.,Landgraf,P.,Iovino,N., Morris,P.,Brownstein,M.J.,Kuramochi-Miyagawa,S.,Nakano,T.,Chien,M.,Russo, J.J.,Ju,J.,Sheridan,R.,Sander,C.,Zavolan, M.,and Tuschl,T.(2006)A novel class of small RNAs bind to MILI protein in mouse testes.Nature,442,203–207.15.Watanabe,T.,Takeda, A.,Tsukiyama,T.,Mise,K.,Okuno,T.,Sasaki,H.,Minami, N.,and Imai,H.(2006)Identification and characterization of two novel classes of small RNAs in the mouse germline: retrotransposon-derived siRNAs in oocytes and germline small RNAs in testes.Genes Dev,20,1732–1743.16.Vagin,V.V.,Sigova,A.,Li,C.,Seitz,H.,Gvozdev,V.,and Zamore,P.D.(2006)A distinct small RNA pathway silences selfish genetic elements in the germline.Science, 313,320–324.17.Saito,K.,Nishida,K.M.,Mori,T.,Kawa-mura,Y.,Miyoshi,K.,Nagami,T.,Siomi,H.,and Siomi,M.C.(2006)Specific asso-ciation of Piwi with rasiRNAs derived from retrotransposon and heterochromatic regions in the Drosophila genome.Genes Dev,20, 2214–2222.18.Ro,S.,Song,R.,Park, C.,Zheng,H.,Sanders,K.M.,and Yan,W.(2007)Cloning and expression profiling of small RNAs expressed in the mouse ovary.RNA,13, 2366–2380.19.Ruby,J.G.,Jan,C.,Player,C.,Axtell,M.J.,Lee,W.,Nusbaum,C.,Ge,H.,and Bartel,D.P.(2006)Large-scale sequencing reveals21U-RNAs and additional microRNAs and endogenous siRNAs in C.elegans.Cell,127, 1193–1207.20.Terns,M.P.and Terns,R.M.(2002)Small nucleolar RNAs:versatile trans-acting molecules of ancient evolutionary origin.Gene Expr,10,17–39.21.Ouellet,D.L.,Perron,M.P.,Gobeil,L.A.,Plante,P.,and Provost,P.(2006)MicroR-NAs in gene regulation:when the smallest governs it all.J Biomed Biotechnol,2006, 69616.22.Maatouk,D.and Harfe,B.(2006)MicroR-NAs in development.ScientificWorldJournal, 6,1828–1840.23.Kim,V.N.and Nam,J.W.(2006)Genomics of microRNA.Trends Genet,22, 165–173.24.Bohnsack,M.T.,Kos,M.,and Tollervey,D.(2008)Quantitative analysis of snoRNAassociation with pre-ribosomes and release of snR30by Rok1helicase.EMBO Rep,9, 1230–1236.25.Hertel,J.,de Jong, D.,Marz,M.,Rose,D.,Tafer,H.,Tanzer, A.,Schierwater,B.,and Stadler,P.F.(2009)Non-codingRNA annotation of the genome of Tri-choplax adhaerens.Nucleic Acids Res,37, 1602–1615.26.Kim,M.,Patel,B.,Schroeder,K.E.,Raza,A.,and Dejong,J.(2008)Organization andtranscriptional output of a novel mRNA-like piRNA gene(mpiR)located on mouse chro-mosome10.RNA,14,1005–1011.27.Mishima,T.,Takizawa,T.,Luo,S.S.,Ishibashi,O.,Kawahigashi,Y.,Mizuguchi, Y.,Ishikawa,T.,Mori,M.,Kanda,T., and Goto,T.(2008)MicroRNA(miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary.Reproduction,136, 811–822.28.Papaioannou,M.D.,Pitetti,J.L.,Ro,S.,Park, C.,Aubry, F.,Schaad,O.,Vejnar,C.E.,Kuhne, F.,Descombes,P.,Zdob-nov, E.M.,McManus,M.T.,Guillou, F., Harfe,B.D.,Yan,W.,Jegou,B.,and Nef, S.(2009)Sertoli cell Dicer is essential for spermatogenesis in mice.Dev Biol,326, 250–259.29.Ro,S.,Park,C.,Sanders,K.M.,McCarrey,J.R.,and Yan,W.(2007)Cloning and expres-sion profiling of testis-expressed microRNAs.Dev Biol,311,592–602.30.Ro,S.,Park,C.,Song,R.,Nguyen,D.,Jin,J.,Sanders,K.M.,McCarrey,J.R.,and Yan, W.(2007)Cloning and expression profiling of testis-expressed piRNA-like RNAs.RNA, 13,1693–1702.31.Ro,S.,Park,C.,Young,D.,Sanders,K.M.,and Yan,W.(2007)Tissue-dependent paired expression of miRNAs.Nucleic Acids Res, 35,5944–5953.32.Siebolts,U.,Varnholt,H.,Drebber,U.,Dienes,H.P.,Wickenhauser,C.,and Oden-thal,M.(2009)Tissues from routine pathol-ogy archives are suitable for microRNA anal-yses by quantitative PCR.J Clin Pathol,62, 84–88.33.Smits,G.,Mungall,A.J.,Griffiths-Jones,S.,Smith,P.,Beury,D.,Matthews,L.,Rogers, J.,Pask, A.J.,Shaw,G.,VandeBerg,J.L., McCarrey,J.R.,Renfree,M.B.,Reik,W.,and Dunham,I.(2008)Conservation of the H19 noncoding RNA and H19-IGF2imprint-ing mechanism in therians.Nat Genet,40, 971–976.34.Song,R.,Ro,S.,Michaels,J.D.,Park,C.,McCarrey,J.R.,and Yan,W.(2009)Many X-linked microRNAs escape meiotic sex chromosome inactivation.Nat Genet,41, 488–493.Quantitative Analysis of Small RNAs30535.Wang,W.X.,Wilfred,B.R.,Baldwin,D.A.,Isett,R.B.,Ren,N.,Stromberg, A.,and Nelson,P.T.(2008)Focus on RNA iso-lation:obtaining RNA for microRNA (miRNA)expression profiling analyses of neural tissue.Biochim Biophys Acta,1779, 749–757.36.Wu,F.,Zikusoka,M.,Trindade,A.,Das-sopoulos,T.,Harris,M.L.,Bayless,T.M., Brant,S.R.,Chakravarti,S.,and Kwon, J.H.(2008)MicroRNAs are differen-tially expressed in ulcerative colitis and alter expression of macrophage inflam-matory peptide-2alpha.Gastroenterology, 135(1624–1635),e24.37.Wu,H.,Neilson,J.R.,Kumar,P.,Manocha,M.,Shankar,P.,Sharp,P.A.,and Manjunath, N.(2007)miRNA profiling of naive,effec-tor and memory CD8T cells.PLoS ONE,2, e1020.38.Yan,W.,Morozumi,K.,Zhang,J.,Ro,S.,Park, C.,and Yanagimachi,R.(2008) Birth of mice after intracytoplasmic injec-tion of single purified sperm nuclei and detection of messenger RNAs and microR-NAs in the sperm nuclei.Biol Reprod,78, 896–902.39.Guryev,V.and Cuppen,E.(2009)Next-generation sequencing approaches in genetic rodent model systems to study func-tional effects of human genetic variation.FEBS Lett.40.Li,W.and Ruan,K.(2009)MicroRNAdetection by microarray.Anal Bioanal Chem.41.Ro,S.,Park,C.,Jin,JL.,Sanders,KM.,andYan,W.(2006)A PCR-based method for detection and quantification of small RNAs.Biochem and Biophys Res Commun,351, 756–763.。
医学英语词缀

医学英语词根词缀基础词根汉义英词希腊源拉丁源例词●前before pro pre prognosis 预后prefrontal前额prostate前列腺precardiac心前的prospective预期的preoperation未来的●上above epi-/hyper- super- superofrontal额上的epithelium上皮superficial表面的,外表epinephrine肾上腺素superantigen上层抗原epigastrium上腹压●下below hypo- sub- subneural神经下的subcutaneous皮下的subcapsular被膜下的hypotension低血压hypoxia低氧症hypothermia低温●内inside endo- intra- endocrine内分泌的endocardiac心内膜endocrinology内分泌学intrauterine子宫内的intravenous静脉下的intracranial颅内的●多many/much poly- multi- polyploidy多尿症polyuria多倍体polymer多聚体multipara经产妇multifactorial多因子multipe sclerosis多发性硬化●同sameness homo- iso- homobody同体homologous chromosome同源染色体homozygote纯合子,同质和子isotope同位素isozyme同功能酶isoantibody同种抗体●异difference allo- hetero- allogeneic异源的allostery立体异构allopathy对抗疗法heterotopia异位heteropathy对症疗法heterograft异体移植●半half hemi- semi- hemisection半切除hemiplegia半身麻痹hemiptera半翅类semiagricultural半农业的semiblind半盲semichemical半化学的●一one mono- uni- uniaxial单轴晶体unicellular单胞的unidirectional单向的mononucleosis单核细胞增多症monoblastic单核细胞性的monoclone单克隆的●二two di- bi- diacid二酸diarthric两关节的diarthusis动关节bicephalous两头的bidental双牙的bicolour双色●三three --- ter-/tri- tertipara三产妇tricuspid三尖瓣trichloroethylene三氯乙烯tertiary第三期的,第三的ter in die每日三次●四four quadric- --- quadriplegic四肢瘫痪tetralogy四联症quadricapsular四囊的,具四蒴的Quadricep Table股四头肌训练台quadribasic四元的,四碱价的●旁/外/副para para- --- parathyroid甲状旁腺paraplegia截瘫parasympathetic副交感的paracervical宫颈旁的paralumbar腰椎旁的●周围peri peri- --- pericardium心包peri effect近位效应periodontal tissue牙周组织peripheral vascular clamp 外周血管夹periscopic lens 周视透镜periscopic spectacles 周视眼镜●大gigant gigant-/ macr(o)-/ mega- /megal(o)- --- gigantic巨大的gigantism巨人症gigantic acid大曲酸macrophage巨噬细胞cytomegalovirus巨细胞病毒hepatomegaly肝肿大药理学汉义英词希腊源拉丁源例词●药drug pharmaco- medicine pharmacogenetics药物遗传学pharmaco-endocrinology药物内分泌学pharmaco-oryctology矿物药物学pharmaceutics 药学pharmacist主任药师pharmacist主管药师,主责药师●疗法treatment -therapy remedy chemotherapy化疗food therapy食物疗法hydrotherapy水疗radiotherapy放疗psychotherapy精神疗法外科学汉义英词希腊源例词●切开cutting -tomy anatomy解剖colotomy结肠切开术hysterotomy子宫切开hernioenterotomy肠疝切开术herniolaparotomy剖腹治疝术●切除cut away -ectomy appendectomy 阑尾切除术colectomy结肠切除术hysterectomy子宫切除nephrolithotomy 肾结石切除术phacocystectomy晶状体囊切除术●造口stoma -stomy gastrostomy胃造口术neostomy造口术racheostomy气管造口术tracheostomy 气管造口术angiostomy 血管●成形shape -plasty cardioplasty贲门成形术plastic operation整形(术)rhinoplasty鼻整形术hernioplasty疝根治术, 疝整复术rhinoplasty 鼻成形术●缝合sew -rrhaphy herniorraphy疝缝手术tenorrhaphy腱缝术nephrorrhaphy 肾缝术duodenorrhaphy 十二指肠缝合术colporrhaphy 阴道缝术●固定术fixation -pexy hepatopexy肝固定术hypopexia固定不足enteropexy肠固定术atrioseptopexy房间隔修补术nephropexy 肾固定术典型词素Typical Morpheme汉义英词希腊源例词●情况situation -ia anoxia缺氧症anorexia厌食症erythropsia红视症ataxia共济失调dementia痴呆hypoplasia发育不全●瘤tumor -oma hepatoma肝细胞瘤angioma血管瘤oncoma肿瘤cerebroma脑瘤,脑肿瘤encephaloma脑瘤,髓样瘤pancreatic carcinoma胰腺瘤aortoma 主动脉瘤●炎症--- -itis hepatitis肝炎rhinitis鼻炎tenositis腱炎pyelonephritis肾盂肾炎appen -dicitis 阑尾炎●痛pain -algia/ -dynia arthralagia关节痛osteodynia骨痛lumbalgia下腰痛,腰痛omodynia肩痛Meuralgia 神经痛Aerodontalgia 牙痛●血症--- -emia leukemia白血病hyperthyroxinemia血甲状腺素过多anemia 贫血anoxemia 无氧血症hyperglycemia 高血糖症病态,状态-osis sclerosis硬化症psychopathic personality psychopathosis病态人格oliguria 少尿症hematuria 血尿diuresis多尿,利尿●缺少,贫乏-penia erythropenia红细胞减少cytopenia血球减少leukopenia白血球减少thrombocytopenia 血小板减少症glycopenia 低血糖●患病状态,疾病-pathy myopathy肌病acropathy四肢病nephropathy肾病pathogenic致病的psychopathy病态人格pathology病理学●细胞cell cyte-/cyt(o)- leukocyte白细胞erythrocyte红细胞cytology细胞学cytoplasm细胞质cytochrome细胞色素●体body -some chromosome染色体mitochondrosome线粒体lysosome溶酶体golgiosome高尔基体centrosome中心体●嗜addict -phil acidophilia嗜酸性basophilia嗜碱性basophil嗜碱细胞basophilic嗜碱性,嗜碱染色的iodinophil嗜碘细胞●杀死kill -cide germicide杀虫剂baceri(o)cide杀(细)菌剂suicide自杀parasuicide自杀企图matricide杀母●溶解dissolve -lysis hemolysis溶血cytolysis细胞溶paralysis 麻痹catalysis 催化作用●溢出extravasate -(o)rrhea diarrhea腹泻galactorrhea amenorrheasyndrome溢乳闭经综合征●恐惧fear -phobe hydrophobia恐水症monophobia孤独恐惧症autophobia孤独恐怖phobia恐怖症,畏惧phobic恐怖的●…学科subject -iatry/-iatrics pediatrics儿科podiatry 足病学psychiatry精神病学obstetrics产科学orthopdics矫形科学auristrics耳科学,gnathostomatics口腔生理学andriatrics男性医学,男性科●…状的shape -form filiform线形的fusiform梭形的bacilliform杆状的dentiform 牙齿状的luniform 月型的●成…细胞-blast osteoblast成骨细胞fibroblast成纤维细胞erythroblast成红细胞histoblast成组织细胞chorioblastoma成绒膜细胞瘤stomatoblast 成口道细胞●破…细胞-clast osteoclast破骨细胞myeloclast破髓鞘细胞osteoclastoma破骨细胞瘤hemoclastic tissue破红细胞组织汉义英词希腊源拉丁源例词●头head cephal- caput- cephalosporin 头孢菌素encephalogram大脑摄影图diencephalon间脑telencephalon 端脑parencephalon小脑caput ulnae 尺骨头caput femoris股骨头caput tali距骨头caput humeri肱骨头caput medusae脐周静脉曲张●劲neck --- cervic- cervicitis子宫颈炎cervical vertebrae 颈椎cervical颈的,子宫颈的cervical abortion子宫颈流产cervical adenitis颈淋巴结炎●胸chest stetho-/thoraco- pectus- pectoral 胸部的pectoralis major胸大肌stethoscope听诊器stethidium胸部thoracic bertebrae胸椎thoracic aorta胸主动脉thoracolumbar 胸腰部的●腹abdomen laparo- abdomino- laparotomy剖腹手术laparoscopy腹腔镜检查abdominocentesis腹腔穿刺术abdominous大肚子的abdominouterotomy剖腹[腹式]子宫切除术●腰loin --- lumbus- lumbosacral腰骶的lumbar puncture腰椎穿刺lumbar vertebrae腰椎lumbar aortography腰(段)主动脉造影(术) lumbal iliac artery髂腰动脉●盆pelvis --- pelvis- pelvimeter骨盆测量器pelvic inflammation盆腔炎pelvirectal骨盆直肠的pelvirectal abscess骨盆直肠脓肿pelviroentgenography骨盆器官X线照相术●肩shoulder omo- --- omodynia肩痛omoplate 肩胛骨omocephalus头不全无上肢畸胎omoclavicular肩锁的omocotyle [肩胛骨]关节盂omohyoid肩胛舌骨的●臂arm --- brachio- brachial臂的brachial plexus臂丛brachialbulb臂膨大(脊髓颈端) brachiocephalic 头臂的brachioradialis 肱桡肌brachiocephalic y[解]头臂动脉●肘elbow --- cubitus- cubital fossa肘窝cubital articulation肘关节cubitoradial bursa肘骨间囊,肘桡骨囊cubitorradial尺桡的cubitoulnar ligament尺侧副韧带●前臂forearm --- antebrachium- antebrachium前臂antebrachial fascia前臂筋膜antebrachial flap前臂皮瓣antebrachial interosseous membrane 前臂骨间膜器官Organs汉义英词希腊源拉丁源例词●腺gland adeno- --- adenoma腺瘤adenocarcinoma腺瘤adenovirus腺病毒;呼吸系统病毒adenomatosis腺上皮增生ribosidoadenine腺(嘌呤核)苷●脑brain encephal(o)- --- encephalatrophy脑萎缩encephalogram大脑摄影图diencephalon间脑telencephalon 端脑parencephalon小脑●脾spleen splen(o)- --- splenomegaly脾肿大splen accessorius副脾splenadenoma脾髓增殖性脾大spleen-renal arterial anastomosis脾-肾动脉吻合术spleen-seeking亲脾性的●睾丸testis –didymus orchid(o)- didymus睾丸orchioepididymitis睾丸附睾炎orchiatrophy睾丸萎缩orchichorea睾丸颤搐orchidoptosis睾丸下垂●子宫womb hyster(o)-/metr(o)- uter(o)- hysterectomy子宫切除术uterogestation妊娠endometriosis子宫内膜异位uteralgia子宫痛metroptosis子宫下垂upper uterine segment子宫上段●乳房breast mast(o)- mamm(o)- mammography乳房X线照像术mastitis乳腺炎mamma aberrans迷离乳房, 额外乳房mamma areolata乳晕运动系统汉义英词希腊源拉丁源例词●椎骨vertebra spondylo- vertebro- cervical vertebrae颈椎thoracicbertebrae胸椎lumbar vertebrae腰椎sacral vertebra骶椎spondylagia脊椎痛●神经nerve neur(o)- --- neurology神经学;神经病学neurocyte神经细胞neurohypophysis神经垂体neurad向神经neuradynamia神经衰弱●肌muscle my (o)- --- myocarditis心肌炎myofilament肌原纤维细丝,肌丝electromyogram肌(动)电(流)图electromyography肌(动)电(流)描记法●脊柱spine rachi(o)- spondyl(o)- rachitis佝偻病,脊柱炎cervicalspondylosis颈椎病rachiagra脊柱猝痛rachial脊柱的spondylagia脊柱痛●骨bone oste(o)- os- osteal骨的osteal resonance骨性叩响osteoporosis骨质疏松症oste(o)arthrotomy骨关节端切除术ostealbumoid骨硬蛋白osteopathy整骨术●关节joint arthr(o)- --- arthritis关节炎arthrotomy关节切开术arthragra关节痛风arthragra abarticularis非关节痛风articulation关节泌尿系统汉义英词希腊源拉丁源例词●肾kidney nephr(o)- ren(o)- nephritis肾炎hepto-renal syndrome肝肾综合症nephrohypertrophy 肾肥大renal肾脏的nephradenoma肾腺瘤nephralgia肾痛nephrosis肾变病nephrotoxic肾中毒的renogram肾x光照片renocortical肾皮质的renovascular肾血管的●肾盂renal pelvis pyelo- pelvi- pyelopathy肾盂病pyelonephritis肾盂肾炎pyelocaliectasis肾盂肾盏扩张pyelocystanastomosis肾盂膀胱吻合术pyelo carcinoma肾盂癌●膀胱bladder cysto- vesico- cystotome膀胱刀cystocele膀胱突出cystoid囊样的,囊状的vesicocolic膀胱结肠的vesica囊,膀胱●尿urine uro- --- urocyst膀胱urolith尿结石uroscopy尿(诊断)检查urogastrone尿抑胃(激)素urology泌尿(科)学uroporphyrin尿卟啉●水water hydro- --- hydromyelia脊髓积水hydronephrosis肾盂积水hydroceophalic脑积水的hydrotherapy水疗法hydrophobia恐水症●球菌coccus cocco- --- coccobacillus球杆菌coccobacillary球杆菌的,类似球杆菌的coccobacillus foetidus ozenae臭鼻球杆菌Gram-negative coccobacillus革兰氏阴性球杆菌coccogenic sycosis 球菌性须疮●结石ston litho- --- litholysis结石溶解lithotomy结石切除术lithotripsy(对肾结石等的)震波碎石lithotomy scoop结石匙lithogenesis结石发生消化系统汉义英词希腊源拉丁源例词●消化digestion peps(o)- gesto- Gestoral 妊娠素Gestormone 黄体酮Gestonorone 孕诺酮pepsin胃蛋白酶Pepsinogen 胃蛋白酶原Pepstatin 胃酶抑素●口mouth stomato- oro- stomatology口腔医学oronasal口鼻的stomatocace溃疡性口炎stomatapsychology精神口腔科学, 口腔心理学stomatitis口腔炎●舌tongue glosso- linguo- glossocele大舌病lingular小舌的glossal deviation舌偏斜lingua adhaerens粘连舌lingua alba白舌lingua dissecta地图样舌●牙tooth odont(o)- dent(o)- odontology牙科学odontalgia牙痛odontagma牙折dentistry牙科医学;牙医业dentition出牙,牙列●肝liver hepat(o)- jeco- hepatomegaly肝肿大hepatalgia肝痛jecoral肝的hepatapostema肝脓肿heparinemia肝素血[症] hepatopexy肝固定术●胆bile chole- /chol(o) bili- bilirubin胆红素cholesterol胆固醇Cholecystitis 胆囊炎Biliary 胆的,胆汁的Bilis 胆汁Biliuria 胆汁尿●胃stomach gastr(o)- --- gastrospasm胃痉挛gastradenitis胃腺炎gastradenitis胃腺炎Gastroenteritis 肠胃炎Gastroenterologist 胃肠病学家Gastrostomy 胃造口术Gastroscope 胃镜●肠gut entero- intestino- enterococcin肠球菌素intestinotoxin肠毒素intestina parva小肠intestinal absorption肠吸收enteritis肠炎●直肠rectum procto- recto- proctectomy直肠切除术rectum直肠Proctology 直肠肛门学Proctocolitis 直肠结肠炎Rectosigmoid 直肠乙状结肠的●肛门anus procto- ano- proctodynia肛部痛anus肛门anal hillock肛丘anal papilla肛乳头anal scute肛[角]板●糖glucose glyco- saccharo- glycogen糖原saccharose蔗糖glycolipide糖脂glycorrhachia糖脊液saccharamide糖二酰胺saccharan多聚糖汉义英词希腊源例词●食道esophagus/gullet esophago- esophagus gland食管腺( = cardic gland ) esophagostenosis食管狭窄mesoesophagus食管系膜esophagogastroduodenoscopy(EGD)食道、胃、十二指肠镜检查●系膜mesenterium meso- mesenterium肠系膜ventral mesogastrium胃腹系膜mesoesophagus mesoappendix阑尾系膜●胃stomach gastr(o)- gastroptosis胃下垂gastric pit胃小凹plexusgastricus superior胃上丛gastrorrhagia胃出血ventral mesogastrium胃腹系膜●酶enzyme -ase collagenase胶原酶lipase脂肪酶protease蛋白酶hydrolase水解酶prohydrolase水解酶原●脂肪fat lip- glycolipide糖脂lipomyohemangioma脂肌血管瘤lipase脂肪酶lipomyoma脂肌瘤liposarcoma脂肉瘤●胆囊gallbladder cholecysto- cholecystography胆囊造影amgiocholecystograph胆管胆囊造影cystic vein胆囊静脉cystic lymph node胆囊淋结cholecystoptosis胆囊下垂●胆管bile cholangio- cholangio-pancreatograph胰胆管造影术cholangiocarcinoma 胆管癌cholangie非炎性胆管病cholangiectasis胆管扩张●幽门pylorus pyloro- pyloric antrum幽门窦pyloroptosis幽门下垂pyloric plexus幽门丛pyloro-oxyntic reflex幽门-泌酸反射心血管系统Cardiovascular System汉义英词希腊源拉丁源例词●心heart cardio- cor- cardiology心脏病学carditis 心肌炎cardiopulmonary心肺cor bovinum牛心症coronary angiography冠状动脉血管造影术cardiovascular心血管的cor pulmonale肺原性心脏病●心房atrium atrio- aurico- atrium心房,前房auricula心房atrial plexus心房丛atrial natriuretic peptide心房(钠尿)肽auricle deflection心房偏转●血blood hema-/hemat(o)-/ hem(o)- sangui- hemoglobin血红蛋白hemodialysis血液透析hemophilia血友病hematology血液学hematocrit血球容积计hematic血的sanguification造血sanguicin血链素●血管blood vessel angi(o)- vas(o)- angiofibroma血管纤维瘤angiogenesis血管再生术angioma血管瘤vascular血管的vasodilation血管舒张angioma血管瘤angiopathy血管病vasospasm血管痉挛vasal管的;血管的●静脉vein phleb(o)- ven(o)- phlebology静脉学phlebography静脉造影术venoclysis静脉输注mesophlebion静脉中层plexus venosus静脉丛phlebitis静脉炎venography静脉造影术●快fast tachy- --- tachycardia心动过速tachypnea呼吸急促Tachy-bradycardia Syndrome心动过速心搏迟缓综合征tachyauxesis生长快速tachyarrhythmia心律失常, 心律加快●慢slow brady- --- bradycardia心动过缓bradyacusia听觉迟钝brady therapy缓释疗法●主动脉aorta aorto- --- aortoma主动脉瘤the arch of aorta主动脉弓aortoptosis主动脉下垂aortic triangle主动脉三角aorto-coronary anastomosis主动脉-冠状动脉吻合术●毛细血管capillary capillo- --- capillarity毛细管作用capillarycondensation毛细冷凝capillometer毛细试验仪capillomotor毛细血管运动的●血栓thrombus thrombo- --- thrombosis血栓形成thrombectomy血栓切除术thrombo-embolism血栓-栓塞机制cerebralthrombosis脑血栓形成coronarythrombosis冠状动脉血栓形成●胸腺thymus thym(o)- --- thymocyte胸腺细胞thymosin胸腺素thymopoietin促胸腺生成素thymulin胸腺(九)肽thymamine胸腺精蛋白●血清serum sero- --- serous浆液性的,血清的 serotonin5-羟色胺,血管收缩素snakebite serum抗蛇毒血清seroresistance血清不应性serotherapy血清(免疫)疗法●淋巴lymph lympho- --- lymphoma淋巴瘤lymphocyte淋巴细胞lymphoid nodule淋巴小结lymphoid triangle淋巴三角alymphoplasia淋巴(组织)发育不全皮肤、感觉器汉义英词希腊源拉丁源例词●皮肤skin dermato- cutaneo- dermatitis皮炎cutaneomucosal皮粘膜的dermatalgia皮痛dermapostasis皮肤脓肿cutaneo-galvanic reaction皮肤电反应cutaneo-muscular reflex皮肤肌肉反射cutaneophalangeal ligaments指(趾)皮韧带●眼eye opthalm(o)- ocul(o)- ophthalmology眼科学ocular ataxia眼球震颤ophthalmosurgery眼外科oculomotor nerve动眼神经oculometric axis视轴●耳ear ot(o)- auri- otitis media中耳炎auriscope耳镜auri laevae左耳otology耳科学otophone助听器auriform耳状的呼吸系统汉义英词希腊源拉丁源例词●呼吸breath pneumo- spiro- pneumocardiography呼吸心动描记法spirography呼吸描记法spirophorus人工呼吸器pnepmopericardium心包积气, 气心包pnermotachography呼吸速度描记●鼻nose rhin(o)- nas(o)- rhinoplasty鼻整形术rhinaeus压鼻孔肌, 鼻肌横部rhinal鼻的, 鼻腔的rhinitis鼻炎rhinologist鼻科学家,鼻科医师rhinology鼻科学nasal鼻的,鼻音的●咽pharynx pharyng(o)- --- pharyngeal咽的anterior pharyngotomy咽上切开术cephalopharyngeus咽上缩肌pharyngeal airway咽导气管pharyngeal probang 咽除鲠器●喉throat laryng-(o) --- otorhinolaryngology 耳鼻喉科otolaryngology laryngal喉音的laryngology喉科学laryngalgia喉痛laryngea phthisis喉结核●肺lung pneumon(o)- pulmo- pneumothorax气胸pulmogram肺X线照片pneumonia肺炎pulmo-aortic肺主动脉的pneumonectasia肺气肿●气管trachea tracheo- --- tracheal triangle气管三角superiortracheotomy气管上部切开术tracheo-esophageal fistula气管食管瘘tracheal gill theory气管鳃翅原说tracheal syrinx气管鸣管tracheal anesthetic atomizer气管麻醉喷雾器●支气管bronchus --- bronch(o)- bronchitis支气管炎bronchoscope支气管镜bronchoscopic支气管镜检查的bronchoscopist支气管镜检查者bronchoscopy支气管镜检查法Parts of Human Body汉义英词希腊源拉丁源例词●腕wrist --- carpus carpoptosis腕下垂carpus curvus 曲腕畸形,马德隆(氏)畸形carpus-ankle acupuncture腕踝针疗法carpocace腕病carpocarpal 腕腕的●手hand cheir(o)- manu- manual用手的,手工的,手册,指南cheirpodagra手足痛cheiragra手痛风●指finger dactyl(o)- digitus- dactylgram指纹dactylagra指(趾)痛风dactylar指(趾)的digitus annularis无名指,环指●股thigh --- femur- femur driver股骨头打入器femurextractor股骨头拔出器●膝knee --- genu- genu capsulae internae内囊膝genucorporis callosi胼胝体膝●小腿leg --- crus- crus ampullare壶腹脚crusantecurvatus小腿弯曲症crus ampullare壶腹脚crus anterius直[前]脚(镫骨)●踝ankle --- talus- talus距骨, 踝, 斜面●足foot pod (o)- ped- pedometer计步器podiatry足医学podiatrist(手)足医peduncle(cerebral)大脑脚诊断汉义英词希腊源例词●表,量器measure -meter diameter直径thermometer温度计barometer气压计permeameter渗透仪,磁导计permeability manometer 渗透压计●度量,测量to measure -metry pelvimetry骨盆测量●图chart -graph photograph照片electrocardiograph心动电流描记器personal biophysiograph肌电生物回授仪●图,像 a mark -gram electrocardiogram心电图kymogram记录(记波,描波)图●书写,记录to write -graphy electrocardiography心动电流描法herniography疝囊造影(术) peritoneography 腹膜造影术positron emission tomography阳电子发射断层摄影术●镜to examine -scope bronchoscope支气管镜cardioscope心脏镜endoscope内窥镜gastroscope胃镜endoscope内镜●检查法to examine -scopy endoscopy内镜检查术fluorescence microscopy荧光镜检查法fluoroscopy荧光透视法biomicroscopy活组织镜检查rhinoscopy照鼻镜检查。
Endocrine System内分泌系统Diabetes糖尿病英文

calc(i)cortic(o)ster/o insulin/o ovari/o andr(o)-
calcium
cortex sterol insulin ovary male
calcipenia钙质减少 hypercalcemia高钙血症 calciuria尿钙
corticosteroid皮质类固醇 corticotropic促肾上腺皮质的 corticoadrenal肾上腺皮质的 steroid类固醇 steroidogenic生成类固醇的 sterolytic可分解类固 醇的 insulinase胰岛素酶 insuloma胰岛细胞瘤 hyperinsulinism胰岛功 能亢进 ovariotomy卵巢切开术 ovaritis卵巢炎 ovariopathy卵巢病 andrology男科学 androgen雄性激素 hyperandrogenism雄激 素过多症
pituipituitary
pituitectomy垂体切除术 hyperpituitarism垂体 neurohypophysis神经垂体 hypophysectomy 垂 thyroidectomy甲状腺切除术 hypothyroidism甲
adrenolytic抗肾上腺的 adrenopathy肾上腺疾
secretive
secret(o)hormon(o)hormone
hormonal激素的 hormonogenesis激素生成 hormonology激素学 pituicyte垂体细胞 机能亢进 hypophyseal垂体的 体切除术 thyroiditis甲状腺炎 状腺功能减退症
adrenitis肾上腺炎 病
The Root and Word Building
root crin(o)meaning example
生理学英文课件(内分泌)Enrinology

Pancreatic secretion ↑
Local Neural Regulation!!
Of course they are right…
Hormone -- Functional Chemical messengers
in Endocrine system
1. Definition and Characteristics 2. Hormone Secretion and transport 3. Mechanisms of Hormone actions
of the following hormones: Growth hormone, Thyroid hormones, Adrenocortical Hormones Insulin Hormones in charge of Calcium and Phosphate
metabolism
immune system, coordinate complex body
functions, such as metabolism, growth and
development, reproduction etc.
Neurectomy
HCl injected
into Small intestine
What is different with these persons?
Chapter 12 Endocrinology
Yu Cui Department of Physiology,
ZMC, SYSU ;:Em虚宇ai文l 中
Main Points
Introduction of endocrine system Hypothalamus-Pituitary system and their hormones Physiological Functions and regulation of secretion
微生物历年考研真题及答案

部分招生单位研究生入学历年考试真题2004年北京师范大学攻读硕士研究生入学考试试题一、名词解释(每题3分,共45分)1.Ames试验 2.包膜 J.胞吞作用 4.不亲和性 5.Col质粒 6.端粒7.附加体 8.感染复数 9.回文结构 10.末端重复 11.轻链 12.噬菌体展示 13.卫星RNA 14.致育因子 15.原毒素二、简要回答题(每题5分,共45分)1.说明控制微生物生长繁殖的主要方法及原理。
2.SASR病毒粒子及其基因组的基本结构是什么?3.以简要的图示和文字说明酿酒酵母菌的生活史。
4.溶源性细菌有哪些特性?5.什么是细菌群体的生长曲线?它在生产上有哪些应用?6.病毒壳体结构有哪几种对称形式?病毒粒子主要结构类型有哪些?7.固氮微生物中大多为好氧菌,它们如何保证固氮酶既不被氧灭活,又能提供必要的氧产生ATP进行固氮?8.说明红硫细菌,枯草杆菌,硝化细菌的营养及获能方式。
9.什么是病毒的一步生长曲线?该曲线中各时期的特点是什么?三、试验设计(每题15分,共30分)1.设计一个实验程序,以确保在对未知菌进行革兰氏染色时操作正确,结果可靠。
2.设计一套从自然界筛选分离一株对聚氯联苯类农药降解能力高的菌株的方案。
四、问答题(每题15分,共30分)1.什么是营养缺陷型?如何从诱变菌株中筛选出营养缺陷型。
2.光合细菌有哪几类?细菌的光合作用与绿色植物的光合作用之间有什么不同?2005年北京师范大学攻读硕士研究生入学考试试题一、名词解释(每题3分,共45分)1.半抗原 2.表型 3.病毒入胞 4.病毒因子 5.超敏反应 6.反向末端重复 7.分段基因组 8.富集培养 9.干扰素 IO.感受态细胞 11.核壳12.类囊体 13.免疫原性 14.原养型 15.微生物传感器二、简要回答题(每题5分,共45分)1.RNA是微生物的遗传物质吗?为什么?2.HIV病毒粒子中的逆转录酶的生物学功能是什么?3.以简要的图示和文字说明路德类酵母菌的生活史。
分子生物学考博试题

分子生物学考博试题2007-02-11 22:10协和医科大学2006年生物化学与分子生物学专业考博试题一、填空(24空24分)1、()年,由()和()(英文姓)首次提出了dna的双螺旋模型,其结果发表在()杂志,他们提出的实验依据是()和()。
2、蛋白质浓度测定在()nm,原因是()但有时候也在220nm 处测量,原因是()。
3、表皮生长因子受体具有()酶的活性。
4、嗅觉、视觉、味觉和细胞膜上的()蛋白结合,这种受体具有()的结构特点,产生的第二信使是()。
二、名词解释(4题16分)1、CpG island2、CTD of RNA Pol II3、SiRNA 三、问答题(4题40分)1、基因组DNA有时会产生G:T错配,DNA复制时有时会发生A:C错配,他们产生的原因是什么,各怎么修复?(12分)2、大肠杆菌的启动子(或操纵子)活性有无强弱之分,如果有,决定其强弱的因素什么?(10分)3、什么是基因印记(imprinting),它是怎么遗传的?举例说明。
(10分)4、为什么说“ribosome is a ribozyme”? (8分)四,名词解释4题8分1、酵母双杂交2、细菌人工染色体五、简述题2题12分1、给定一个组织,简述如何构建Cdna文库。
2、简述基因敲除小鼠模型的策略。
协和医科大学2005年博士入学分子生物学试题一、名词:前四个是关于基本理论的,后四选二是关于实验技术的。
Kozak sequence;SD sequence;attenuator;?亲和层析;?;?;?二、问答:1、是关于Z-DNA和回文序列的结构特点和功能的;2、转录过程中进行起始定位的因子是什么?该因子在转录全过程是否都存在?为什么?现已经体外科隆并纯化该蛋白,它能否单独与DNA结合?为什么?3、?4、什么是“epigenetic mutation”?如何导致的?三、试验设计题:1、已知某基因与某蛋白能够相互作用,设计实验证明并找出作用位点。
不同浓度DSS诱导小鼠溃疡性结肠炎模型的比较

不同浓度DSS诱导小鼠溃疡性结肠炎模型的比较李晴;胡丽红;曲波【摘要】目的对比研究不同浓度葡聚糖硫酸钠(dextran sulfate sodium,DSS)诱导的小鼠溃疡性结肠炎(ulcerative colitis,UC)模型,从不同角度监测炎症反应程度,为实验造模提供理论数值,并选择最佳的造模方案.方法用BALB/C小鼠自由饮用DSS溶液的方法建立低浓度(3%)和高浓度(5%)模型组,正常对照组饮用蒸馏水,每组24只.分别于第0天、3天、7天对小鼠进行动态观察:疾病活动指数(disease activity index,DAI)、结肠组织病理学改变、血清中HGB、CRP、TNF-α的表达、结肠黏膜中MOP、SOD、NF-κB的表达及NF-κB核转位情况、绘制小鼠生存曲线.结果 HGB、SOD与UC疾病活动程度呈负相关,CRP、TNF-α、MOP、NF-KB 与UC疾病活动程度呈正相关,均表现出明显的时间和剂量依赖性.结论随着造模浓度和时间的增加,小鼠模型UC的炎症程度也逐渐加重,但死亡率也随之增加,得出3%DSS溶液喂养7d建立的UC小鼠模型为最佳.【期刊名称】《胃肠病学和肝病学杂志》【年(卷),期】2016(025)010【总页数】5页(P1106-1110)【关键词】葡聚糖硫酸钠;小鼠;溃疡性结肠炎;造模【作者】李晴;胡丽红;曲波【作者单位】哈尔滨医科大学附属第二医院消化内科,黑龙江哈尔滨150086;哈尔滨医科大学附属第二医院消化内科,黑龙江哈尔滨150086;哈尔滨医科大学附属第二医院消化内科,黑龙江哈尔滨150086【正文语种】中文【中图分类】R574.62溃疡性结肠炎(ulcerative colitis, UC)是一种病因和发病机制尚不明确的慢性非特异性肠道炎性病变,发病率在我国逐年上升,其发病机制并不明确,治疗也缺乏特异性方法,成为近些年消化领域的热点。
葡聚糖硫酸钠(dextran sulfate sodium, DSS)诱导的小鼠UC模型的肠道病变与人类UC肠道病理形态变化最为相近[1],因此被广泛应用。
NJQ

Leading EdgeReviewChromatin:Receiver and Quarterbackfor Cellular SignalsDavid G.Johnson1,2,3and Sharon Y.R.Dent1,2,3,*1Department of Molecular Carcinogenesis2Center for Cancer EpigeneticsThe University of Texas MD Anderson Cancer Center,Science Park,Smithville,TX78957,USA3The University of Texas Graduate School of Biomedical Sciences at Houston,Houston,TX77030,USA*Correspondence:sroth@/10.1016/j.cell.2013.01.017Signal transduction pathways converge upon sequence-specific DNA binding factors to reprogram gene expression.Transcription factors,in turn,team up with chromatin modifying activities. However,chromatin is not simply an endpoint for signaling pathways.Histone modifications relay signals to other proteins to trigger more immediate responses than can be achieved through altered gene transcription,which might be especially important to time-urgent processes such as the execution of cell-cycle check points,chromosome segregation,or exit from mitosis.In addition, histone-modifying enzymes often have multiple nonhistone substrates,and coordination of activity toward different targets might direct signals both to and from chromatin.IntroductionSignal transduction classically involves coordinated cascades of protein phosphorylation or dephosphorylation,which in turn alter protein conformation,protein-protein interactions,subcel-lular protein locations,or protein stability.In many cases,these pathways begin at the cell surface and extend into the nucleus, where they alter the interactions of transcription factors and chromatin-modifying enzymes with the chromatin template.In some cases,signaling promotes such interactions,whereas in others,factors are ejected from chromatin in response to incoming signals.Several such pathways have been defined that control developmental fate decisions or response to physi-ological or environmental changes(for examples,see Fisher and Fisher,2011;Long,2012;Valenta et al.,2012).In these cases, the ultimate endpoint of the signal is often considered to be a modification of chromatin structure to modulate DNA accessi-bility to control gene expression.The architecture of chromatin can be altered by a variety of mechanisms,including posttranslational modification of histones,alterations in nucleosome locations,and exchange of canonical histones for histone variants.Histone modifications have at least three nonmutually exclusive effects on chromatin packing(Butler et al.,2012;Suganuma and Workman,2011). First,modifications such as acetylation or phosphorylation can alter DNA:histone and histone:histone interactions.Second, histone acetylation,methylation,and ubiquitylation can create binding sites for specific protein motifs,thereby directly promoting or inhibiting interactions of regulatory factors with chromatin(Smith and Shilatifard,2010;Yun et al.,2011).Bromo-domains,for example,promote interactions with acetyl-lysines within histones.PHD domains,Tudor domains,and chromo domains can selectively bind particular methylated lysines (Kme).At least one Tudor domain(TDRD3)serves as a reader for methylarginine(Rme)residues(Yang et al.,2010).In contrast, other domains,such as the PhDfinger in BHC80(Lan et al., 2007),are repelled by lysine methylation.Such regulation is enhanced by combining domains to create multivalent‘‘readers’’of histone modification patterns(Ruthenburg et al.,2007).The combination of PhD and bromodomains in the TRIM24protein, for example,creates a motif that specifically recognizes histone H3K23acetylation in the absence of H3K4methylation(Tsai et al.,2010).Third,histone modifications also affect the chro-matin landscape by influencing the occurrence of other modifi-cations at nearby sites(Lee et al.,2010).Methylation of H3R2, for example,inhibits methylation of H3K4,but not vice versa (Hyllus et al.,2007;Iberg et al.,2008).Such modification‘‘cross-talk’’can result either from direct effects of a pre-existing modi-fication on the ability of a second histone-modifying enzyme to recognize its substrate site or from indirect effects on substrate recognition through the recruitment of‘‘reader proteins’’that mask nearby modification sites.Binding of the chromodomain in the HP1protein to H3K9me blocks subsequent phosphoryla-tion of S10by Aurora kinases,for example(Fischle et al.,2003). The Power of CrosstalkHistone modification crosstalk can also occur in trans between sites on two different histones.The most studied example of such crosstalk is the requirement of H2B monoubiquitylation for methylation of H3K4(Shilatifard,2006).In yeast,the Bre1 E3ligase ubiquitylates H2BK123and works together with the Paf1complex to recruit the Set1H3K4methyltransferase complex,often referred to as COMPASS,to gene promoters (Lee et al.,2010).Bre1-mediated H2B ubiquitylation also stimulates H3K79methylation by the Dot1methyltransferase (Nakanishi et al.,2009;Ng et al.,2002).Each of these histone modifications is widely associated with activelytranscribed Cell152,February14,2013ª2013Elsevier Inc.685genes and can regulate multiple steps during transcription (Laribee et al.,2007;Mohan et al.,2010;Wyce et al.,2007). These crosstalk events are conserved,at least in part,in mammalian systems(Kim et al.,2009;Zhou et al.,2011). Though H2B ubiquitylation is observed in the bodies of all actively transcribed genes,knockdown of the mammalian homolog of Bre1,ringfinger protein20(RNF20),affects the expression of only a small subset of genes(Shema et al., 2008).Interestingly,RNF20depletion not only led to the repres-sion of some genes,but also caused the upregulation of others. Genes negatively regulated by RNF20and H2B ubiquitylation include several proto-oncogenes,such as c-MYC and c-FOS, as well as other positive regulators of cell proliferation.On the other hand,depletion of RNF20and reduction in H2B ubiquityla-tion reduced the expression of the p53tumor suppressor gene and impaired the activation of p53in response to DNA damage. Consistent with these selective changes in gene expression, RNF20depletion elicited a number of phenotypes associated with oncogenic transformation.The suggestion that RNF20 may function as a tumor suppressor is further supported by thefinding of decreased levels of RNF20and H3K79methylation in testicular seminomas(Chernikova et al.,2012)and the obser-vation that the RNF20promoter is hypermethylated in some breast cancers(Shema et al.,2008).A more concrete link between these histone modifications and human cancer comes from leukemias bearing translocations of the mixed lineage leukemia(MLL)gene.MLL is a H3K4methyl-transferase related to the yeast Set1protein found in theCOMPASS complex.A number of different gene partners are found to be translocated to the MLL locus,and this invariably creates an MLL fusion protein that lacks H3K4methyltransferase activity.Interestingly,many of the translocation partners are part of a‘‘superelongation complex’’that stimulates progress of the polymerase through gene bodies(Mohan et al.,2010;Smith et al.,2011).Data suggest that at least some of these oncogenic MLL fusion proteins alter the expression of select target genes, such as HOXA,by increasing H3K79methylation(Okada et al., 2005).Knockdown of Dot1reduced H3K79methylation at these targets and inhibited oncogenic transformation by MLL fusion proteins.These examples demonstrate how deregulation of crosstalk among different histone modifications can contribute to diseases such as cancer.Not Just for HistonesJust as in histones,modifications in nonhistone proteins are subject to regulatory crosstalk and serve as platforms for binding of‘‘reader’’proteins.For example,a yeast kinetochore protein, Dam1,is methylated at K233by the Set1methyltransferase,an ortholog of mammalian MLL proteins(Zhang et al.,2005).The functions of Dam1,like those of other kinetochore proteins,are highly regulated by Aurora-kinase-mediated phosphorylation (Lampson and Cheeseman,2011).At least some of these phos-phorylation events are inhibited by prior methylation of Dam1, creating a phosphomethyl switch that impacts chromosome segregation(Zhang et al.,2005).Another more complicated example of a phosphomethyl regu-latory cassette occurs in the RelA subunit of NF-k B(Levy et al., 2011).RelA is monomethylated by SETD6at K310,and this modification inhibits RelA functions in transcriptional activation through recruitment of another methyltransferase,G9a-like protein(GLP).GLP binds to K310me1in RelA and induces a repressive histone modification,H3K9me,in RelA target genes. Phosphorylation of the adjacent S311in RelA,however,blocks GLP association with RelA and instead promotes the recruitment of CREB-binding protein(CBP)to activate transcription of NF-k B targets(Duran et al.,2003)(Figure1A).These two examples in yeast and in mammalian cells likely foreshadow the discovery of many additional regulatory ‘‘switches’’created by modification crosstalk.The p53tumor suppressor is a prime candidate for such regulation,as it harbors several diverse modifications.Moreover,many kinase con-sensus sites contain arginine or lysine residues,providing a high potential for phosphomethyl,phosphoacetyl,or phosphou-biquitin switches(Rust and Thompson,2011).The induction of H3K9me by recruitment of GLP via a methyl-ation event in RelA illustrates how a signaling pathway,in this case mediated by NF-k B,can transduce a signal to chromatin. However,signaling can also occur in the other direction;that is,a histone modification can affect the modification state of a nonhistone protein.Methylation of Dam1,for example,requires ubiquitylation of histone H2B(Latham et al.,2011).Most likely, H2Bub recruits the Set1complex to centromeric nucleosomes, positioning it for methylation of Dam1at the kinetochore.Thus, transregulation of posttranslational modifications can occur both between histones(such as H2Bub and H3K4me)and between histones and nonhistones(such as H2Bub and Dam1-K233me),providing a platform for bidirectional signaling fromchromatin.Figure1.Regulation of RelA/NF-k B by a Phosphomethyl Switch and in Response to DNA Damage(A)Methylation of RelA at lysine310(K310)by SETD6creates a binding site for GLP,which in turn methylates H3K9at NF-k B target genes to inhibit tran-scription.Phosphorylation of RelA at serine311(S311)by PKC z blocks binding of GLP to RelA(Levy et al.,2011)and,along with other RelA modifications not shown,promotes its interaction with CBP,leading to histone acetylation and activation of NF-k B target genes(Duran et al.,2003).(B)Phosphorylation of NEMO by ATM in response to a DSB promotes its export from the nucleus.In the cytoplasm,NEMO activates the IKK complex, leading to I k B phosphorylation and degradation and NF-k B(RelA-p50) translocation to the nucleus,where it can activate transcription as shown in(A). Note that some ATM may translocate with NEMO to the cytoplasm and participate in IKK activation.686Cell152,February14,2013ª2013Elsevier Inc.Signaling to and from Chromatin in Response to DNA DamageSignaling to and from chromatin impacts other important cellular processes as well.DNA repair involves coordination among the repair machinery,chromatin modifications,and cell-cycle checkpoint signaling.At the apex of the DNA damage response are three kinases related to the PI3kinase family,ataxia telangi-ectasia mutated(ATM),ATM and Rad3-related protein(ATR), and DNA-PK(Jackson and Bartek,2009;Lovejoy and Cortez, 2009).DNA-PK is activated when its regulatory subunit Ku70/ 80binds to the end of a DNA double-strand break(DSB).ATR activation involves recognition of single-stranded DNA coated with replication protein A(RPA)by the ATR-interacting protein, ATRIP,as well as direct interaction with topoisomerase II b-bind-ing protein(TopBP1)(Burrows and Elledge,2008).Like DNA-PK, ATM is also activated in response to DSBs,but rather than recognition of broken DNA ends,ATM appears to be activated in response to large-scale changes in chromatin structure caused by a DSB(Bakkenist and Kastan,2003).How alterations in chromatin structure are signaled to ATM is at present unclear. One of the earliest events in the DNA damage response is the phosphorylation of a variant of histone H2A,H2AX,by ATM, DNA-PK,and/or ATR(Rogakou et al.,1998).Phosphorylated H2AX(g H2AX)provides a mediator of DNA damage signaling directed by these kinases,and this modification is found inflank-ing chromatin regions as far as one megabase from a DNA DSB. This phosphorylation event creates a binding motif for the medi-ator of DNA damage checkpoint(MDC1)protein,which in turn recruits other proteins,such as Nijmegen breakage syndrome 1(NBS1)and RNF8,to sites of DSBs through additional phos-pho-specific interactions(Chapman and Jackson,2008;Kolas et al.,2007;Stucki and Jackson,2006).NBS1is part of the MRN complex that also contains Mre11and Rad50and is involved in DNA end processing for both the homologous recom-bination and nonhomologous end-joining pathways of DSB repair(Zha et al.,2009).In addition,NBS1functions as a cofactor for ATM by stimulating its kinase activity and recruiting ATM to sites of DSBs where many of it substrates are located(Lovejoy and Cortez,2009;Zha et al.,2009).ATM also phosphorylates effector proteins that only transiently localize to DSBs.One of these proteins is the checkpoint2(Chk2)kinase,which can be activated by ATM-mediated phosphorylation at sites of damage but then spreads throughout the nucleus to phosphorylate and regulate additional proteins as part of the DNA damage response (Bekker-Jensen et al.,2006).ATM also phosphorylates tran-scription factors,such as p53and E2F1,to regulate the expres-sion of numerous genes involved in the cellular response to DSBs(Banin et al.,1998;Biswas and Johnson,2012;Canman et al.,1998;Lin et al.,2001).These events again illustrate that signals to chromatin,in this case resulting in H2AX phosphoryla-tion,can be relayed to other proteins both on and off of the chro-matin-DNA template.Bidirectional signaling is illustrated even further by another branch of the ATM-mediated DNA damage response that involves activation of NF-k B.NF-k B is normally sequestered in an inactive state in the cytoplasm through its association with I k B.Following ATM activation by a DNA DSB,ATM phosphory-lates NF-k B essential modulator(NEMO)in the nucleus(Wu et al.,2006),which promotes additional modifications to NEMO and export from the nucleus to the cytoplasm.Once in the cytoplasm,NEMO participates in the activation of the canon-ical inhibitor of NF-k B(I k B)kinase(IKK)complex that targets I k B for degradation,leading to NF-k B activation.NF-k B then trans-locates to the nucleus,where it regulates the expression of genes that are important for cell survival following DNA damage. In this case,a change in chromatin structure caused by a DSB initiates a signal that travels to the cytoplasm and back to the nucleus to activate transcription of NF-k B target genes by modi-fying chromatin structure(Figure1).Multiple Roles for H2B UbiquitylationIn addition to phosphorylation of H2A/H2AX,a number of other histone modifications are induced at sites of DSBs in yeast and mammalian cells.One such modification is H2Bub,the same mark involved in regulating transcription as described above.As with transcription,the Bre1ubiquitin ligase(RNF20-RNF40in mammalian cells)is responsible for H2Bub at sites of DNA damage(Game and Chernikova,2009;Moyal et al.,2011; Nakamura et al.,2011).Moreover,H2Bub is required for and promotes H3K4and H3K79methylation at sites of damage, similar to its role at actively transcribed genes.These histone modifications are important for altering chromatin structure to allow access to repair factors involved in DNA end resection and processing(Moyal et al.,2011;Nakamura et al.,2011). Moreover,H2Bub and H3K79me are not only required for DNA repair but are also important for activating the Rad53kinase and for imposing subsequent cell-cycle checkpoints(Giannat-tasio et al.,2005).Blocking H2B ubiquitylation or H3K79methyl-ation in response to DSBs inhibits Rad53activation and impairs the G1and intra S phase checkpoints.Bre1-mediated H2B ubiquitylation and subsequent methyla-tion of H3K4by Set1and H3K79by Dot1are also involved in regulating mitotic exit in yeast.The Cdc14phosphatase controls mitotic exit by dephosphorylating mitotic cyclins and their substrates during anaphase(D’Amours and Amon,2004).Prior to anaphase,Cdc14is sequestered on nucleolar chromatin through interaction with its inhibitor,the Cf1/Net1protein.Two pathways,Cdc fourteen early anaphase release(FEAR)and mitotic exit network(MEN),control the release of Cdc14from ribosomal DNA(rDNA)in the nucleolus.Upon inactivation of the MEN pathway,H2B ubiquitylation and methylation of H3K4 and H3K79are necessary for FEAR-pathway-mediated release of Cdc14from the nucleolus(Hwang and Madhani,2009).It appears that alteration of rDNA chromatin structure induced by these modifications is important for this process.Thus,depending on its chromosomal location,H2Bub can regulate gene transcription,DNA repair and checkpoint sig-naling,mitotic exit,and chromosome segregation(Figure2). The ability of this modification to affect methylation of both histone(H3K4and H3K79)and nonhistone proteins in trans high-lights its potential to serve as a nexus of signals coming into and emanating from chromatin.Unanswered QuestionsThe roles of H2B ubiquitylation and H3K4and H3K79meth-ylation in regulating nontranscriptional processes are well Cell152,February14,2013ª2013Elsevier Inc.687established in yeast.An unanswered question is whether these histone modifications regulate similar cellular processes in hu-mans.If so,then defects in chromatin signaling,independent of transcription,could contribute to diseases associated with alterations in histone-modifying enzymes.At present,studies aimed at understanding the oncogenic properties of MLL fusion proteins have focused on their abilities to regulate transcription.Likewise,the putative tumor suppressor function of RNF20is assumed to be due to selective regulation of certain genes (Shema et al.,2008).However,it is possible that defects in the DNA damage response or chromosomal segregation might contribute to the oncogenic properties of MLL fusion proteins or participate in the transformed phenotype associated with depletion of RNF20.Indeed,RNF20was recently shown to localize to sites of DNA DSBs to promote repair and maintain genome stability,a function that is apparently independent of transcriptional regulation.The importance of chromatin organization and reorganization for the regulation of gene expression and other DNA-templated processes cannot be argued.Defining how such changes are triggered by incoming signals is clearly important for under-standing how cells respond to changes in their environment,developmental cues,or insults to genomic integrity.However,emerging studies indicate that chromatin is not simply an obstacle to gene transcription or DNA repair.Rather,it is an active participant in these processes that can provide real-time signals to facilitate,amplify,or terminate cellular responses.Given the regulatory potential of modification crosstalk within histones and between histone and nonhistone proteins,coupled with ongoing definitions of vast networks of protein methylation,acetylation,and ubiquitylation events,our current view of signaling pathways as ‘‘one-way streets’’that dead end at chro-matin is likely soon to be converted into a view of chromatin as an information hub that directs multilayered and multidirec-tional regulatory networks.Defining these networks will not only provide a greater understanding of biological processes,but will also provide entirely new game plans for combatingcomplex human diseases that result from inappropriate signal transduction.ACKNOWLEDGMENTSWe thank Becky Brooks for preparation of the manuscript,Chris Brown for graphics,and Mark Bedford and Boyko Atanassov for suggestions and insightful comments.This research is supported,in part,by grants from the National Institutes of Health (CA079648to D.G.J.and GM096472and GM067718to S.R.D.)and through MD Anderson’s Cancer Center Support Grant (CA016672).REFERENCESBakkenist, C.J.,and Kastan,M.B.(2003).DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.Nature 421,499–506.Banin,S.,Moyal,L.,Shieh,S.,Taya,Y.,Anderson,C.W.,Chessa,L.,Smoro-dinsky,N.I.,Prives,C.,Reiss,Y.,Shiloh,Y.,and Ziv,Y.(1998).Enhanced phosphorylation of p53by ATM in response to DNA damage.Science 281,1674–1677.Bekker-Jensen,S.,Lukas,C.,Kitagawa,R.,Melander,F.,Kastan,M.B.,Bartek,J.,and Lukas,J.(2006).Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks.J.Cell Biol.173,195–206.Biswas,A.K.,and Johnson,D.G.(2012).Transcriptional and nontranscriptional functions of E2F1in response to DNA damage.Cancer Res.72,13–17.Published online December 16,2011./10.1158/0008-5472.CAN-11-2196.Burrows,A.E.,and Elledge,S.J.(2008).How ATR turns on:TopBP1goes on ATRIP with ATR.Genes Dev.22,1416–1421.Butler,J.S.,Koutelou,E.,Schibler,A.C.,and Dent,S.Y.(2012).Histone-modifying enzymes:regulators of developmental decisions and drivers of human disease.Epigenomics 4,163–177.Canman,C.E.,Lim,D.S.,Cimprich,K.A.,Taya,Y.,Tamai,K.,Sakaguchi,K.,Appella,E.,Kastan,M.B.,and Siliciano,J.D.(1998).Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.Science 281,1677–1679.Chapman,J.R.,and Jackson,S.P.(2008).Phospho-dependent interactions between NBS1and MDC1mediate chromatin retention of the MRN complex at sites of DNA damage.EMBO Rep.9,795–801.Chernikova,S.B.,Razorenova,O.V.,Higgins,J.P.,Sishc,B.J.,Nicolau,M.,Dorth,J.A.,Chernikova,D.A.,Kwok,S.,Brooks,J.D.,Bailey,S.M.,et al.(2012).Deficiency in mammalian histone H2B ubiquitin ligase Bre1(Rnf20/Rnf40)leads to replication stress and chromosomal instability.Cancer Res.72,2111–2119.D’Amours, D.,and Amon, A.(2004).At the interface between signaling and executing anaphase—Cdc14and the FEAR network.Genes Dev.18,2581–2595.Duran,A.,Diaz-Meco,M.T.,and Moscat,J.(2003).Essential role of RelA Ser311phosphorylation by zetaPKC in NF-kappaB transcriptional activation.EMBO J.22,3910–3918.Fischle,W.,Wang,Y.,and Allis,C.D.(2003).Binary switches and modification cassettes in histone biology and beyond.Nature 425,475–479.Fisher,C.L.,and Fisher,A.G.(2011).Chromatin states in pluripotent,differen-tiated,and reprogrammed cells.Curr.Opin.Genet.Dev.21,140–146.Game,J.C.,and Chernikova,S.B.(2009).The role of RAD6in recombinational repair,checkpoints and meiosis via histone modification.DNA Repair (Amst.)8,470–482.Giannattasio,M.,Lazzaro,F.,Plevani,P.,and Muzi-Falconi,M.(2005).The DNA damage checkpoint response requires histone H2B ubiquitination by Rad6-Bre1and H3methylation by Dot1.J.Biol.Chem.280,9879–9886.Figure 2.H2Bub Passes Signals to Different ReceiversIn yeast,Bre1-mediated ubiquitylation of H2B promotes H3K4and Dam1methylation by Set1and H3K79methylation by Dot1.Depending on its loca-tion,H2Bub can participate in the regulation of transcription,chromosome segregation,cell-cycle checkpoints,and mitotic exit.688Cell 152,February 14,2013ª2013Elsevier Inc.Hwang,W.W.,and Madhani,H.D.(2009).Nonredundant requirement for multiple histone modifications for the early anaphase release of the mitotic exit regulator Cdc14from nucleolar chromatin.PLoS Genet.5,e1000588. Hyllus,D.,Stein,C.,Schnabel,K.,Schiltz,E.,Imhof,A.,Dou,Y.,Hsieh,J.,and Bauer,U.M.(2007).PRMT6-mediated methylation of R2in histone H3antag-onizes H3K4trimethylation.Genes Dev.21,3369–3380.Iberg,A.N.,Espejo,A.,Cheng,D.,Kim,D.,Michaud-Levesque,J.,Richard,S., and Bedford,M.T.(2008).Arginine methylation of the histone H3tail impedes effector binding.J.Biol.Chem.283,3006–3010.Jackson,S.P.,and Bartek,J.(2009).The DNA-damage response in human biology and disease.Nature461,1071–1078.Kim,J.,Guermah,M.,McGinty,R.K.,Lee,J.S.,Tang,Z.,Milne,T.A.,Shilati-fard,A.,Muir,T.W.,and Roeder,R.G.(2009).RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4methylation in human cells.Cell137,459–471.Kolas,N.K.,Chapman,J.R.,Nakada,S.,Ylanko,J.,Chahwan,R.,Sweeney, F.D.,Panier,S.,Mendez,M.,Wildenhain,J.,Thomson,T.M.,et al.(2007). Orchestration of the DNA-damage response by the RNF8ubiquitin ligase. Science318,1637–1640.Lampson,M.A.,and Cheeseman,I.M.(2011).Sensing centromere tension: Aurora B and the regulation of kinetochore function.Trends Cell Biol.21, 133–140.Lan,F.,Collins,R.E.,De Cegli,R.,Alpatov,R.,Horton,J.R.,Shi,X.,Gozani,O., Cheng,X.,and Shi,Y.(2007).Recognition of unmethylated histone H3lysine4 links BHC80to LSD1-mediated gene repression.Nature448,718–722. Laribee,R.N.,Fuchs,S.M.,and Strahl,B.D.(2007).H2B ubiquitylation in tran-scriptional control:a FACT-finding mission.Genes Dev.21,737–743. Latham,J.A.,Chosed,R.J.,Wang,S.,and Dent,S.Y.(2011).Chromatin signaling to kinetochores:transregulation of Dam1methylation by histone H2B ubiquitination.Cell146,709–719.Lee,J.S.,Smith,E.,and Shilatifard,A.(2010).The language of histone cross-talk.Cell142,682–685.Levy,D.,Kuo,A.J.,Chang,Y.,Schaefer,U.,Kitson,C.,Cheung,P.,Espejo,A., Zee,B.M.,Liu,C.L.,Tangsombatvisit,S.,et al.(2011).Lysine methylation of the NF-k B subunit RelA by SETD6couples activity of the histone methyltrans-ferase GLP at chromatin to tonic repression of NF-k B signaling.Nat.Immunol. 12,29–36.Lin,W.C.,Lin,F.T.,and Nevins,J.R.(2001).Selective induction of E2F1in response to DNA damage,mediated by ATM-dependent phosphorylation. Genes Dev.15,1833–1844.Long,F.(2012).Building strong bones:molecular regulation of the osteoblast lineage.Nat.Rev.Mol.Cell Biol.13,27–38.Lovejoy,C.A.,and Cortez,D.(2009).Common mechanisms of PIKK regula-tion.DNA Repair(Amst.)8,1004–1008.Mohan,M.,Lin,C.,Guest,E.,and Shilatifard,A.(2010).Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.Nat.Rev.Cancer 10,721–728.Moyal,L.,Lerenthal,Y.,Gana-Weisz,M.,Mass,G.,So,S.,Wang,S.Y.,Eppink, B.,Chung,Y.M.,Shalev,G.,Shema,E.,et al.(2011).Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks.Mol.Cell41,529–542.Nakamura,K.,Kato,A.,Kobayashi,J.,Yanagihara,H.,Sakamoto,S.,Oliveira, D.V.,Shimada,M.,Tauchi,H.,Suzuki,H.,Tashiro,S.,et al.(2011).Regulation of homologous recombination by RNF20-dependent H2B ubiquitination.Mol. Cell41,515–528.Nakanishi,S.,Lee,J.S.,Gardner,K.E.,Gardner,J.M.,Takahashi,Y.H.,Chan-drasekharan,M.B.,Sun,Z.W.,Osley,M.A.,Strahl,B.D.,Jaspersen,S.L.,and Shilatifard, A.(2009).Histone H2BK123monoubiquitination is the critical determinant for H3K4and H3K79trimethylation by COMPASS and Dot1.J. Cell Biol.186,371–377.Ng,H.H.,Xu,R.M.,Zhang,Y.,and Struhl,K.(2002).Ubiquitination of histone H2B by Rad6is required for efficient Dot1-mediated methylation of histone H3lysine79.J.Biol.Chem.277,34655–34657.Okada,Y.,Feng,Q.,Lin,Y.,Jiang,Q.,Li,Y.,Coffield,V.M.,Su,L.,Xu,G.,and Zhang,Y.(2005).hDOT1L links histone methylation to leukemogenesis.Cell 121,167–178.Rogakou,E.P.,Pilch,D.R.,Orr,A.H.,Ivanova,V.S.,and Bonner,W.M.(1998). DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139.J.Biol.Chem.273,5858–5868.Rust,H.L.,and Thompson,P.R.(2011).Kinase consensus sequences: a breeding ground for crosstalk.ACS Chem.Biol.6,881–892.Ruthenburg,A.J.,Allis,C.D.,and Wysocka,J.(2007).Methylation of lysine4on histone H3:intricacy of writing and reading a single epigenetic mark.Mol.Cell 25,15–30.Shema,E.,Tirosh,I.,Aylon,Y.,Huang,J.,Ye,C.,Moskovits,N.,Raver-Shapira,N.,Minsky,N.,Pirngruber,J.,Tarcic,G.,et al.(2008).The histone H2B-specific ubiquitin ligase RNF20/hBRE1acts as a putative tumor suppressor through selective regulation of gene expression.Genes Dev.22, 2664–2676.Shilatifard,A.(2006).Chromatin modifications by methylation and ubiquitina-tion:implications in the regulation of gene expression.Annu.Rev.Biochem. 75,243–269.Smith,E.,and Shilatifard,A.(2010).The chromatin signaling pathway:diverse mechanisms of recruitment of histone-modifying enzymes and varied biolog-ical outcomes.Mol.Cell40,689–701.Smith,E.,Lin,C.,and Shilatifard,A.(2011).The super elongation complex (SEC)and MLL in development and disease.Genes Dev.25,661–672.Stucki,M.,and Jackson,S.P.(2006).gammaH2AX and MDC1:anchoring the DNA-damage-response machinery to broken chromosomes.DNA Repair (Amst.)5,534–543.Suganuma,T.,and Workman,J.L.(2011).Signals and combinatorial functions of histone modifications.Annu.Rev.Biochem.80,473–499.Tsai,W.W.,Wang,Z.,Yiu,T.T.,Akdemir,K.C.,Xia,W.,Winter,S.,Tsai,C.Y., Shi,X.,Schwarzer,D.,Plunkett,W.,et al.(2010).TRIM24links a non-canonical histone signature to breast cancer.Nature468,927–932.Valenta,T.,Hausmann,G.,and Basler,K.(2012).The many faces and func-tions of b-catenin.EMBO J.31,2714–2736.Wu,Z.H.,Shi,Y.,Tibbetts,R.S.,and Miyamoto,S.(2006).Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.Science311,1141–1146.Wyce,A.,Xiao,T.,Whelan,K.A.,Kosman,C.,Walter,W.,Eick,D.,Hughes, T.R.,Krogan,N.J.,Strahl,B.D.,and Berger,S.L.(2007).H2B ubiquitylation acts as a barrier to Ctk1nucleosomal recruitment prior to removal by Ubp8 within a SAGA-related complex.Mol.Cell27,275–288.Yang,Y.,Lu,Y.,Espejo,A.,Wu,J.,Xu,W.,Liang,S.,and Bedford,M.T.(2010). TDRD3is an effector molecule for arginine-methylated histone marks.Mol. Cell40,1016–1023.Yun,M.,Wu,J.,Workman,J.L.,and Li,B.(2011).Readers of histone modifi-cations.Cell Res.21,564–578.Zha,S.,Boboila,C.,and Alt,F.W.(2009).Mre11:roles in DNA repair beyond homologous recombination.Nat.Struct.Mol.Biol.16,798–800.Zhang,K.,Lin,W.,Latham,J.A.,Riefler,G.M.,Schumacher,J.M.,Chan,C., Tatchell,K.,Hawke,D.H.,Kobayashi,R.,and Dent,S.Y.(2005).The Set1 methyltransferase opposes Ipl1aurora kinase functions in chromosome segregation.Cell122,723–734.Zhou,V.W.,Goren,A.,and Bernstein,B.E.(2011).Charting histone modifica-tions and the functional organization of mammalian genomes.Nat.Rev.Genet. 12,7–18.Cell152,February14,2013ª2013Elsevier Inc.689。
NATURE RNA-Seq a revolutionary tool for transcriptomics

The transcriptome is the complete set of transcripts in a cell, and their quantity, for a specific developmental stage or physi-ological condition. Understanding the transcriptome is essential for interpreting the functional elements of the genome and revealing the molecular constituents of cells and tissues, and also for understand-ing development and disease. The key aims of transcriptomics are: to catalogue all species of transcript, including mRNAs, non-coding RNAs and small RNAs; to determine the transcriptional structureof genes, in terms of their start sites, 5′and 3′ ends, splicing patterns and other post-transcriptional modifications; and to quantify the changing expression levels of each transcript during development and under different conditions.Various technologies have been developed to deduce and quantify the transcriptome, including hybridization- or sequence-based approaches. Hybridization-based approaches typically involve incubating fluorescently labelled cDNA with custom-made microarrays or commercial high-density oligo microar-rays. Specialized microarrays have also been designed; for example, arrays with probes spanning exon junctions canbe used to detect and quantify distinct spliced isoforms1. Genomic tiling microar-rays that represent the genome at high density have been constructed and allow the mapping of transcribed regions to avery high resolution, from several basepairs to ~100 bp2–5. Hybridization-basedapproaches are high throughput andrelatively inexpensive, except for high-resolution tiling arrays that interrogatelarge genomes. However, these methodshave several limitations, which include:reliance upon existing knowledge aboutgenome sequence; high background levelsowing to cross-hybridization6,7; and alimited dynamic range of detection owingto both background and saturation ofsignals. Moreover, comparing expressionlevels across different experiments is oftendifficult and can require complicatednormalization methods.In contrast to microarray methods,sequence-based approaches directly deter-mine the cDNA sequence. Initially, Sangersequencing of cDNA or EST libraries8,9was used, but this approach is relativelylow throughput, expensive and generallynot quantitative. Tag-based methods weredeveloped to overcome these limitations,including serial analysis of gene expression(SAGE)10,11, cap analysis of gene expression(CAGE)12–14 and massively parallel signaturesequencing (MPSS)15–17. These tag-basedsequencing approaches are high through-put and can provide precise, ‘digital’ geneexpression levels. However, most arebased on expensive Sanger sequencingtechnology, and a significant portion ofthe short tags cannot be uniquely mappedto the reference genome. Moreover, onlya portion of the transcript is analysed andisoforms are generally indistinguishablefrom each other. These disadvantageslimit the use of traditional sequencingtechnology in annotating the structure oftranscriptomes.Recently, the development of novelhigh-throughput DNA sequencing meth-ods has provided a new method for bothmapping and quantifying transcriptomes.This method, termed RNA-Seq (RNAsequencing), has clear advantages overexisting approaches and is expected to rev-olutionize the manner in which eukaryotictranscriptomes are analysed. It has alreadybeen applied to Saccharomyces cerevisiae,Schizosaccharomyces pombe, Arabidopsisthaliana, mouse and human cells18–24. Here,we explain how RNA-Seq works, discussits challenges and provide an overview ofstudies that have used this approach, whichhave already begun to change our view ofeukaryotic transcriptomes.RNA-Seq technology and benefitsRNA-Seq uses recently developed deep-sequencing technologies. In general, apopulation of RNA (total or fractionated,such as poly(A)+) is converted to a libraryof cDNA fragments with adaptors attachedto one or both ends (FIG. 1). Each molecule,with or without amplification, is thensequenced in a high-throughput mannerto obtain short sequences from one end(single-end sequencing) or both ends(pair-end sequencing).The reads are typi-cally 30–400 bp, depending on the DNA-sequencing technology used. In principle,any high-throughput sequencing technol-ogy25 can be used for RNA-Seq, and theIllumina IG18–21,23,24, Applied BiosystemsSOLiD22 and Roche 454 Life Science26–28I N N OVAT I O NRNA-Seq: a revolutionary tool fortranscriptomicsZhong Wang, Mark Gerstein and Michael SnyderAbstract | RNA-Seq is a recently developed approach to transcriptome profilingthat uses deep-sequencing technologies. Studies using this method havealready altered our view of the extent and complexity of eukaryotictranscriptomes. RNA-Seq also provides a far more precise measurement oflevels of transcripts and their isoforms than other methods. This article describesthe RNA-Seq approach, the challenges associated with its application, and theadvances made so far in characterizing several eukaryote transcriptomes.RNA-Seq […] is expectedto revolutionize themanner in which eukaryotictranscriptomes are analysed.NATURE REVIEwS |genetics VOLUME 10 | jANUARy 2009 |57PeRSPecTiveS© 2009 Macmillan Publishers Limited. All rights reservedsystems have already been applied for this purpose. The Helicos Biosciences tSMS system has not yet been used for published RNA-Seq studies, but is also appropriate and has the added advantage of avoiding amplification of target cDNA. Following sequencing, the resulting reads are either aligned to a reference genome or reference transcripts, or assembledde novo without the genomic sequenceto produce a genome-scale transcription map that consists of both the transcrip-tional structure and/or level of expression for each gene.Although RNA-Seq is still a technology under active development, it offers several key advantages over existing technologies (Table 1).First, unlike hybridization-based approaches, RNA-Seq is not limited to detecting transcripts that correspondto existing genomic sequence. For example, 454-based RNA-Seq has beenused to sequence the transcriptome ofthe Glanville fritillary butterfly27. Thismakes RNA-Seq particularly attractivefor non-model organisms with genomicsequences that are yet to be determined.RNA-Seq can reveal the precise locationof transcription boundaries, to a single-base resolution. Furthermore, 30-bp shortreads from RNA-Seq give informationabout how two exons are connected,whereas longer reads or pair-end shortreads should reveal connectivity betweenmultiple exons. These factors make RNA-Seq useful for studying complex tran-scriptomes. In addition, RNA-Seq can alsoreveal sequence variations (for example,SNPs) in the transcribed regions22,24.A second advantage of RNA-Seqrelative to DNA microarrays is thatRNA-Seq has very low, if any, backgroundsignal because DNA sequences canbeen unambiguously mapped to uniqueregions of the genome. RNA-Seq doesnot have an upper limit for quantifica-tion, which correlates with the numberof sequences obtained. Consequently,it has a large dynamic range of expres-sion levels over which transcripts can bedetected: a greater than 9,000-fold rangewas estimated in a study that analysed 16million mapped reads in Saccharomycescerevisiae18, and a range spanning fiveorders of magnitude was estimated for40 million mouse sequence reads20. Bycontrast, DNA microarrays lack sensitivityfor genes expressed either at low or veryhigh levels and therefore have a muchsmaller dynamic range (one-hundredfoldto a few-hundredfold) (FIG. 2). RNA-Seqhas also been shown to be highly accuratefor quantifying expression levels, as deter-mined using quantitative PCR (qPCR)18 andspike-in RNa controls of known concentra-tion20. The results of RNA-Seq also showhigh levels of reproducibility, for bothtechnical and biological replicates18,22.Finally, because there are no cloning steps,and with the Helicos technology there isno amplification step, RNA-Seq requiresless RNA sample.Taking all of these advantages intoaccount, RNA-Seq is the first sequencing-based method that allows the entiretranscriptome to be surveyed in a veryhigh-throughput and quantitative man-ner. This method offers both single-baseresolution for annotation and ‘digital’gene expression levels at the genome scale,often at a much lower cost than eithertiling arrays or large-scale Sanger ESTsequencing.Challenges for RNA-SeqLibrary construction.The ideal methodfor transcriptomics should be able todirectly identify and quantify all RNAs,small or large. Although there are onlya few steps in RNA-Seq (FIG. 1), it doesinvolve several manipulation stages dur-ing the production of cDNA libraries,which can complicate its use in profilingall types of transcript.Unlike small RNAs (microRNas(miRNAs), Piwi-interacting RNas (piRNAs),short interfering RNas (siRNAs)and manyothers), which can be directly sequencedafter adaptor ligation, larger RNA mol-ecules must be fragmented into smallerpieces (200–500 bp) to be compatiblewith most deep-sequencing technologies.Common fragmentation methods includeCoding sequenceORFP e r s P e c t i v e s58 | jANUARy 2009 | VOLUME 10 /reviews/genetics© 2009 Macmillan Publishers Limited. All rights reservedRNA fragmentation (RNA hydrolysis or nebulization) and cDNA fragmentation (DNase I treatment or sonication). Each of these methods creates a different bias in the outcome. For example, RNA fragmen-tation has little bias over the transcript body20, but is depleted for transcript ends compared with other methods (FIG. 3). Conversely, cDNA fragmentation is usually strongly biased towards the iden-tification of sequences from the 3′ ends of transcripts, and thereby provides valuable information about the precise identity of these ends18 (FIG. 4).Some manipulations during library construction also complicate the analysis of RNA-Seq results. For example, many shorts reads that are identical to each other can be obtained from cDNA librariesthat have been amplified. These could bea genuine reflection of abundant RNAspecies, or they could be PCR artefacts.One way to discriminate between thesepossibilities is to determine whether thesame sequences are observed in differentbiological replicates.Another key consideration concerninglibrary construction is whether or not toprepare strand-specific libraries, as hasbeen done in two studies21,22. These librarieshave the advantage of yielding informationabout the orientation of transcripts, whichis valuable for transcriptome annotation,especially for regions with overlappingtranscription from opposite directions2,19,29;however, strand-specific libraries arecurrently laborious to produce because theyrequire many steps22 or direct RNA–RNAligation21, which is inefficient. Moreover,it is essential to ensure that the antisensetranscripts are not artefacts of reverse tran-scription30. Because of these complications,most studies thus far have analysed cDNAswithout strand information.Bioinformatic challenges.Like otherhigh-throughput sequencing technolo-gies, RNA-Seq faces several informaticschallenges, including the development ofefficient methods to store, retrieve andprocess large amounts of data, which mustbe overcome to reduce errors in imageanalysis and base-calling and removelow-quality reads.Table 1 |Advantages of RNA-Seq compared with other transcriptomics methodsP e r s P e c t i v e sOnce high-quality reads have been obtained, the first task of data analysis is to map the short reads from RNA-Seq to the reference genome, or to assemble them into contigs before aligning them to the genomic sequence to reveal transcription structure. There are several programs for mapping reads to the genome, including ELAND, SOAP31, MAQ32 and RMAP33 (information about these can be found atthe Illumina forum and at SEQanswers).However, short transcriptomic reads also only needs to be given to poly(A) tailsand to a small number of exon–exonjunctions. Poly(A) tails can be identifiedsimply by the presence of multiple As orTs at the end of some reads. Exon–exonjunctions can be identified by the pres-ence of a specific sequence context (theGT–AG dinucleotides that flank splicesites) and confirmed by the low expressionof intronic sequences, which are removedduring splicing. Transcriptome mapsa junction library that contains all theknown and predicted junction sequencesand map reads to this library19,20. A chal-lenge for the future is to develop computa-tionally simple methods to identify novelsplicing events that take place between twodistant sequences or between exons fromtwo different genes.For large transcriptomes, alignmentis also complicated by the fact that a sig-nificant portion of sequence reads matchP e r s P e c t i v e sgenes are presumably either not expressed under this condition (for example, sporu-lation genes18) or do not have poly(A) tails. Analyzing many different conditions can further increase the coverage; inS. pombe 122 million reads from six differ-ent growth conditions detected transcrip-tion from >99% of annotated genes19.In general, the larger the genome, the more complex the transcriptome, the more sequencing depth is required for adequate coverage. Unlike genome-sequencing cov-erage, it is less straightforward to calculate the coverage of the transcriptome; thisis because the true number and level of different transcript isoforms is not usually known and because transcription activity varies greatly across the genome. One study used the number of unique transcription start sites as a measure of coverage in mouse embryonic cells, and demonstrated that at 80 million reads, the number of start sites reached a plateau22 (FIG. 5b). However, this approach does not address transcrip-tome complexity in alternative splicing and transcription termination sites; presumably further sequencing can reveal additionalvariants.New transcriptomic insights Despite the challenges described above, the advantages of RNA-Seq have enabled us to generate an unprecedented global view of the transcriptome and its organi-zation for a number of species and cell types. Before the advent of RNA-Seq,it was known that a much greater than expected fraction of the yeast, Drosophila melanogaster and human genomes are transcribed2,4,36, and for yeast and humans a number of distinct isoforms have been found for many genes2,4. However, the starts and ends of most transcripts and exons had not been precisely resolved and the extent of spliced heterogeneity remained poorly understood. RNA-Seq, with its high resolution and sensitivity has revealed many novel transcribed regions and splicing isoforms of known genes, and has mapped 5′ and 3′ boundaries for many genes.Mapping gene and exon boundaries. The single-base resolution of RNA-Seq has the potential to revise many aspectsof the existing gene annotation, including gene boundaries and introns for known genes as well as the identification of novel transcribed regions. 5′ and 3′ boundaries can be mapped to within 10–50 bases by a precipitous drop in signal. 3′ boundaries can be precisely mapped by searching forpoly(A) tags, and introns can be mappedby searching for tags that span GT–AGsplicing consensus sites. Using these meth-ods the 5′ and 3′ boundaries of 80% and85% of all annotated genes, respectively,were mapped in S. cerevisiae18. Similarly,in S. pombe many boundaries were definedby RNA-Seq data in combination withtiling array data19.These two studies led to the discoveryof many 5′ and 3′ UTRs that had notbeen analysed previously. In S. cerevisiae,extensive 3′-end heterogeneity wasdiscovered at two levels: first, localheterogeneity exists in which a cluster ofsites are involved, typically within a 10 bpwindow; second, there are distinct regionsof poly(A) addition for 540 genes (FIG. 4).It is plausible that these different 3′ endsconfer distinct properties to the differentmRNA isoforms, such as mRNA localiza-tion or degradation signals, which in turnmight be responsible for unique biologicalfunctions18,19. In addition to 3′ heterogene-ity, the list of upstream ORFs within the 5′UTRs of mRNAs (uORFs) was also greatlyexpanded from 17 to 340 (6% of yeastgenes)18; uORFs regulate mRNA transla-tion37 or stability38, so these sequencesmight make a previously underappreciatedcontribution to the regulatory sophistica-tion of eukaryotic genomes. Interestingly,many mRNAs with uORFs are transcrip-tion factors, suggesting that these regulatorsare themselves heavily regulated.The mapping of transcript boundariesrevealed several novel features of eukaryo-tic gene organization. Many yeast geneswere found to overlap at their 3′ ends18.Using relaxed criteria similar to thoseemployed in a recent study18 we found that808 pairs, approximately 25% of all yeastORFs, overlap at their 3′ ends18. Likewise,antisense expression is enriched in the 3′exons of mouse transcripts22. These featuresmight confer interesting regulatory proper-ties on the affected genes. For multicellularorganisms, antisense transcription couldmodulate gene expression through theproduction of siRNAs or through dsRNaediting39,40. For yeast, which seems to lacksiRNA and dsRNA-editing functions,transcription from one gene might interferewith that from an overlapping gene, orcoordinate gene expression through othermechanisms.Extensive transcript complexity.RNA-Seqcan be used to quantitatively examinesplicing diversity by searching for readsthat span known splice junctions as wellas potential new ones. In humans, 31,618known splicing events were confirmed(11% of all known splicing events) and 379novel splicing events were discovered24.ture Reviews |Genetics′Local heterogeneityDistinct poly(A) sitesFigure 4 | Poly(A) tags from RnA-seq. A region containing two overlapping transcripts (ACT1, from the actin gene, and YFL040W, an uncharacterized ORF) from the Saccharomyces cerevisiae genome is shown. Arrows point to transcription direction. The poly(A) tags from RNA-Seq experiments are shown below these transcripts, with arrows indicating transcription direction. The precise location of each locus identified by poly(A) tags reveals the heterogeneity in poly(A) sites, for example, ACT1 has two big clusters, both with a few bases of local heterogeneity. The transcription direction revealed by poly(A) tags also helps to resolve 3′-end overlapping transcribed regions18.P e r s P e c t i v e sNATURE REVIEwS |genetics VOLUME 10 | jANUARy 2009 |61© 2009 Macmillan Publishers Limited. All rights reservedglossaryCap analysis of gene expression(CaGe). Similar to SaGe, except that 5′-end information of the transcript is analysed instead of 3′-end information. ContigsA group of sequences representing overlapping regions from a genome or transcriptome.dsRNA editingSite-specific modification of a pre-mRNa by dsRNa-specific enzymes that leads to the production of variant mRNa from the same gene.Genomic tiling microarraya DNa microarray that uses a set of overlapping oligonucleotide probes that represent a subset of or the whole genome at very high resolution.Massively parallel signature sequencing (MPSS). a gene expression quantification method that determines 17–20-bp ‘signatures’ from the ends of a cDNa molecule using multiple cycles of enzymatic cleavage and ligation.MicroRNA(miRNa). Small RNa molecules that areprocessed from small hairpin RNa (shRNa)precursors that are produced from miRNagenes. miRNas are 21–23 nucleotides in lengthand through the RNa-induced silencing complexthey target and silence mRNas containing imperfectlycomplementary sequence.Piwi-interacting RNAs(piRNa). Small RNa species that are processedfrom single-stranded precursor RNas. Theyare 25–35 nucleotides in length and formcomplexes with the piwi protein. piRNas areprobably involved in transposon silencing andstem-cell function.Quantitative PCR(qPCR). an application of PCR to determinethe quantity of DNa or RNa in a sample. Themeasurements are often made in real time andthe method is also called real-time PCR.Sequencing depthThe total number of all the sequences reads or basepairs represented in a single sequencing experiment orseries of experiments.Serial analysis of gene expression(SaGe). a method that uses short ~14–20-bp sequencetags from the 3′ ends of transcripts to measure geneexpression levels.Short interfering RNA(siRNa). RNa molecules that are 21–23 nucleotides longand that are processed from long double-stranded RNas;they are functional components of the RNai-inducedsilencing complex. siRNas typically target and silencemRNas by binding perfectly complementary sequencesin the mRNa and causing their degradation and/ortranslation inhibition.Spike-in RNAa few species of RNa with known sequence and quantitythat are added as internal controls in RNa-Seq experiments.62 | jANUARy 2009 | VOLUME 10 /reviews/genetics© 2009 Macmillan Publishers Limited. All rights reservedDefining transcription levelAs RNA-Seq is quantitative, it can be used to determine RNA expression levels more accurately than microarrays. In principle, it is possible to determine the absolute quantity of every molecule in a cell population, and directly compare results between experiments. Several methods have been used for quantification. For RNA fragmentation followed by cDNA synthesis, which gives more uniform cov-erage of each exon, gene expression levels can be deduced from the total numberof reads that fall into the exons of a gene, normalized by the length of exons that can be uniquely mapped24; for 3′-biased methods, read counts from a window near the 3′ end are used18. Gene expression levels determined by these methods closely correlate with qPCR and RNA spike-in controls.One particularly powerful advantage of RNA-Seq is that it can capture transcrip-tome dynamics across different tissues or conditions without sophisticated normali-zation of data sets19,20,22. RNA-Seq has been used to accurately monitor gene expres-sion during yeast vegetative growth18, yeast meiosis19 and mouse embryonic stem-cell differentiation22, to track gene expression changes during development, and to provide a ‘digital measurement’ of gene expression difference between differ-ent tissues20. Because of these advantages, RNA-Seq will undoubtedly be valuable for understanding transcriptomic dynamics during development and normal physi-ological changes, and in the analysis of biomedical samples, where it will allow robust comparison between diseased and normal tissues, as well as the subclassification of disease states.Future directionsAlthough RNA-Seq is still in the early stages of use, it has clear advantages over previously developed transcriptomic methods. The next big challenge for RNA-Seq is to target more complex transcriptomes to identify and track the expression changes of rare RNA isoforms from all genes. Technologies that will advance achievement of this goal are pair-end sequencing, strand-specific sequencing and the use of longer reads to increase coverage and depth. As the cost of sequencing continues to fall, RNA-Seq is expected to replace microarrays for many applications that involve determin-ing the structure and dynamics of the transcriptome.Zhong Wang and Michael Snyder are at the Departmentof Molecular, Cellular and Developmental Biology, andMark Gerstein is at the Department of Molecular,Biophysics and Biochemistry, Yale University, 219Prospect Street, New Haven, Connecticut 06520, USA.Correspondence to M.S.e‑mail: michael.snyder@doi:10.1038/nrg2484Published online 18 November 20081. Clark, T. A., Sugnet, C. W. & Ares, M. Jr.Genomewide analysis of mRNA processing in yeastusing splicing-specific microarrays. Science296,907–910 (2002).2. David, L. et al. A high-resolution map of transcriptionin the yeast genome. Proc. Natl Acad. Sci. USA103,5320–5325 (2006).3. Yamada, K. et al. Empirical analysis of transcriptionalactivity in the Arabidopsis genome. Science 302,842–846 (2003).4. Bertone, P. et al. Global identification of humantranscribed sequences with genome tiling arrays.Science 306, 2242–2246 (2004).5. Cheng, J. et al. T ranscriptional maps of 10 humanchromosomes at 5-nucleotide resolution. Science308, 1149–1154 (2005).6. Okoniewski, M. J. & Miller, C. J. Hybridizationinteractions between probesets in short oligomicroarrays lead to spurious correlations.BMC Bioinformatics7, 276 (2006).7. Royce, T. E., Rozowsky, J. S. & Gerstein, M. B.T oward a universal microarray: prediction of geneexpression through nearest-neighbor probe sequenceidentification. Nucleic Acids Res.35, e99 (2007).8. Boguski, M. S., T olstoshev, C. M. & Bassett, D. E. Jr.Gene discovery in dbEST. Science 265, 1993–1994(1994).9. Gerhard, D. S. et al. The status, quality, and expansionof the NIH full-length cDNA project: the MammalianGene Collection (MGC). Genome Res.14, 2121–2127(2004).10. Velculescu, V. E., Zhang, L., Vogelstein, B. &Kinzler, K. W. Serial analysis of gene expression.Science270, 484–487 (1995).11. Harbers, M. & Carninci, P. T ag-based approaches fortranscriptome research and genome annotation.Nature Methods2, 495–502 (2005).12. Kodzius, R. et al. CAGE: cap analysis of geneexpression. Nature Methods3, 211–222 (2006).13. Nakamura, M. & Carninci, P. [Cap analysis geneexpression: CAGE]. T anpakushitsu Kakusan Koso49,2688–2693 (2004) (in Japanese).14. Shiraki, T. et al. Cap analysis gene expressionfor high-throughput analysis of transcriptional startingpoint and identification of promoter usage. Proc. NatlAcad. Sci. USA100, 15776–15781 (2003).15. Brenner, S. et al. Gene expression analysis bymassively parallel signature sequencing (MPSS) onmicrobead arrays. Nature Biotechnol.18, 630–634(2000).16. Peiffer, J. A. et al. A spatial dissection of theArabidopsis floral transcriptome by MPSS.BMC Plant Biol.8, 43 (2008).17. Reinartz, J. et al. Massively parallel signaturesequencing (MPSS) as a tool for in-depth quantitativegene expression profiling in all organisms. Brief. Funct.Genomic Proteomic1, 95–104 (2002).18. Nagalakshmi, U. et al. The transcriptional landscapeof the yeast genome defined by RNA sequencing.Science 320, 1344–1349 (2008).19. Wilhelm, B. T. et al. Dynamic repertoire of a eukaryotictranscriptome surveyed at single-nucleotideresolution. Nature453, 1239–1243 (2008).20. Mortazavi, A., Williams, B. A., McCue, K.,Schaeffer, L. & Wold, B. Mapping and quantifyingmammalian transcriptomes by RNA-Seq. NatureMethods5, 621–628 (2008).21. Lister, R. et al. Highly integrated single-base resolutionmaps of the epigenome in Arabidopsis.Cell133, 523–536 (2008).22. Cloonan, N. et al. Stem cell transcriptome profilingvia massive-scale mRNA sequencing. Nature Methods5, 613–619 (2008).23. Marioni, J., Mason, C., Mane, S., Stephens, M. &Gilad, Y. RNA-seq: an assessment of technicalreproducibility and comparison with gene expressionarrays. Genome Res. 11 Jun 2008 (doi:10.1101/gr.079558.108).24. Morin, R. et al. Profiling the HeLa S3 transcriptomeusing randomly primed cDNA and massively parallelshort-read sequencing. Biotechniques45, 81–94(2008).25. Holt, R. A. & Jones, S. J. The new paradigm of flow cellsequencing. Genome Res.18, 839–846 (2008).26. Barbazuk, W. B., Emrich, S. J., Chen, H. D., Li, L. &Schnable, P. S. SNP discovery via 454 transcriptomesequencing. Plant J.51, 910–918 (2007).27. Vera, J. C. et al. Rapid transcriptome characterizationfor a nonmodel organism using 454 pyrosequencing.Mol. Ecol.17, 1636–1647 (2008).28. Emrich, S. J., Barbazuk, W. B., Li, L. & Schnable, P. S.Gene discovery and annotation using LCM-454transcriptome sequencing. Genome Res.17, 69–73(2007).29. Dutrow, N. et al. Dynamic transcriptome ofSchizosaccharomyces pombe shown by RNA–DNAhybrid mapping. Nature Genet.40, 977–986(2008).30. Wu, J. Q., et al. Systematic analysis of transcribed lociin ENCODE regions using RACE sequencing revealsextensive transcription in the human genome. GenomeBiol.9, R3 (2008).31. Li, R., Li, Y., Kristiansen, K. & Wang, J. SOAP: shortoligonucleotide alignment program. Bioinformatics24, 713–714 (2008).32. Li, H., Ruan, J. & Durbin, R. Mapping short DNAsequencing reads and calling variants using mappingquality scores. Genome Res. 19 Aug 2008(doi:10.1101/gr.078212.108).33. Smith, A. D., Xuan, Z. & Zhang, M. Q. Usingquality scores and longer reads improves accuracyof Solexa read mapping. BMC Bioinformatics9,128 (2008).34. Hillier, L. W. et al. Whole-genome sequencing andvariant discovery in C. elegans. Nature Methods5,183–188 (2008).35. Campbell, P. J. et al. Identification of somaticallyacquired rearrangements in cancer using genome-widemassively parallel paired-end sequencing. NatureGenet.40, 722–729 (2008).36. Manak, J. R. et al. Biological function ofunannotated transcription during the earlydevelopment of Drosophila melanogaster. NatureGenet.38, 1151–1158 (2006).37. Hinnebusch, A. G. T ranslational regulation of GCN4and the general amino acid control of yeast. Annu.Rev. Microbiol.59, 407–450 (2005).38. Ruiz-Echevarria, M. J. & Peltz, S. W. The RNA bindingprotein Pub1 modulates the stability of transcriptscontaining upstream open reading frames. Cell101,741–751 (2000).39. T omari, Y. & Zamore, P. D. MicroRNA biogenesis:drosha can’t cut it without a partner. Curr. Biol.15,R61–64 (2005).40. Bass, B. L. How does RNA editing affect dsRNA-mediated gene silencing? Cold Spring Harb. Symp.Quant. Biol.71, 285–292 (2006).41. Sultan, M. et al. A global view of gene activityand alternative splicing by deep sequencing of thehuman transcriptome. Science 321, 956–960(2008).42. Ross-Macdonald, P. et al. Large-scale analysis of theyeast genome by transposon tagging and genedisruption. Nature402, 413–418 (1999).43. Kumar, A., des Etages, S. A., Coelho, P. S.,Roeder, G. S. & Snyder, M. High-throughputmethods for the large-scale analysis of gene functionby transposon tagging. Methods Enzymol.328,550–574 (2000).AcknowledgementsWe thank D. Raha for many valuable comments.P e r s P e c t i v e sNATURE REVIEwS |genetics VOLUME 10 | jANUARy 2009 |63© 2009 Macmillan Publishers Limited. All rights reserved。
睾丸穿刺取精及手淫射出精子行ICSI治疗结局的比较分析

临床医学China &Foreign Medical Treatment 中外医疗睾丸穿刺取精及手淫射出精子行ICSI 治疗结局的比较分析叶宇,甄国志,麦福劲,甄锦壮,林冰广东医科大学顺德妇女儿童医院(佛山市顺德区妇幼保健院)生殖科,广东佛山 528300[摘要] 目的 比较睾丸穿刺取精及手淫射出精子进行卵胞浆内单精子注射(intracytoplasmic sperm injection, ICSI )的临床结局。
方法 方便选取2020年3月—2021年3月来广东医科大学顺德妇女儿童医院进行治疗的不育症患者332例作为研究对象。
根据取精方式的不同分为睾丸穿刺取精组(A 组,n =64)和手淫射出精子组(B 组,n =268),女方常规超排卵和取卵,成熟卵子行ICSI 注射,比较两组患者的正常受精率、正常卵裂率、可利用胚胎率、优质胚胎率、临床妊娠率。
结果 两组正常受精率、正常卵裂率、可利用胚胎率、优质胚胎率,差异无统计学意义(P >0.05),A 组临床妊娠率73.44%高于B 组57.46%,差异有统计学意义(χ2=5.519,P =0.019)。
结论 对于不育的男性能够通过一些技术孕育下一代,对不育男性采用睾丸中取出精子的方式可以有效改善患者不育现状,帮助患者繁育下一代,在临床治疗不育症中效果良好。
[关键词] 睾丸取出精子;手淫射出精子;临床妊娠率[中图分类号] R698.2 [文献标识码] A [文章编号] 1674-0742(2023)04(c)-0065-04Comparative Analysis of the Outcome of ICSI Treatment for Testicular Puncture and Ejaculation Sperm by MasturbationYE Yu, ZHEN Guozhi, MAI Fujin, ZHEN Jinzhuang, LIN BingDepartment of Reproductive Medicine, Shunde Women and Children's Hospital of Guangdong Medical University (Foshan Shunde District Maternal and Child Health Hospital), Foshan, Guangdong Province, 528300 China[Abstract] Objective To compare the clinical outcomes of intracytoplasmic single sperm injection (ICSI) between tes⁃ticular puncture and ejaculated sperm by masturbation. Methods A total of 332 infertile patients who received treat⁃ment in Shunde Women and Children's Hospital of Guangdong Medical University from March 2020 to March 2021 were conveniently selected as subjects. According to different methods of sperm extraction, they were divided into tes⁃tis puncture group (group A, n =64) and masturbation ejaculation sperm group (group B, n =268). The woman under⁃went routine superovulation and ovulation, and the mature ovum underwent ICSI injection. The normal fertilization rate, normal cleavage rate, available embryo rate, high-quality embryo rate and clinical pregnancy rate were compared between the two groups. Results There was no statistically significant difference in the normal fertilization rate, normal cleavage rate, available embryo rate, high-quality embryo rate in two groups (P >0.05). The clinical pregnancy rate of the group A was 73.44%, which was higher than that of the group B (57.46%), and the difference was statistically sig⁃nificant (χ2=5.519, P =0.019). Conclusion For infertile men, the next generation can be conceived through some tech⁃nologies. The method of removing sperm from testicles for infertile men can effectively improve the status quo of infer⁃tility in patients and help patients to breed the next generation, which has a good effect in the clinical treatment of in⁃fertility.[Key words] Sperm removal from testis; Masturbation ejaculation sperm; Clinical pregnancy rate DOI :10.16662/ki.1674-0742.2023.12.065[作者简介] 叶宇(1986-),男,本科,主治医师,主要从事生殖男科及泌尿外科工作。
分子生物学-第5章-分子生物研究法(上)可编辑全文

1958 -Matthew Meselson & Franklin Stahl proved that DNA replication in bacteria follows the semiconservative pathway
Parent cell
Frank Stahl
First replication
Tetracycline resistance gene
E. coli transformed with recombinant plasmid
Transformed cells plated onto medium with kanamycin and tetracycline
Only cells with recombinant plasmid survive to produce
SV40 DNA
仅仅能在体外利用限制性核酸内切酶和DNA连接 酶进行DNA的切割和重组远不能满足基因研究的需 要。
DNA片段在体外不具备自我复制能力,要想得到 足够量和足够纯度的DNA,必须将它们连接到具备 自主复制能力的DNA分子上(载体上),并转入寄 主细胞中进行繁殖。
这就是基因克隆,或分子克隆 。
两大技术保证: 1.DNA的体外切割和连接
1962年Arber 发现限制性核酸内切酶,1967Gellert发现了 DNA 连接酶DNA ligase covalently links two DNA strands
3’
5’
Restriction enzyme
Ligase
5’
3’
Restriction enzyme
分子克隆的载 体----具备自主 复制能力的 DNA分子( vector),如 病毒、噬菌体 和质粒等小分 子量复制子都 可以作为基因 导入的载体。
和医疗相关的英语词汇

和医疗相关的英语词汇Medical Terminology.Introduction.Medical terminology is the language of healthcare professionals. It is essential for clear and precise communication about medical conditions, procedures, and treatments. This article will provide an overview of some of the most common medical terms, organized by anatomical system.Musculoskeletal System.Arthrology: The study of joints.Myology: The study of muscles.Osteology: The study of bones.Anatomy The study of physical structure.Biopsy A procedure to remove a small tissue sample for examination.Cartilage A connective tissue found in joints and other parts of the body.Ligament A band of tissue that connects bones.Muscle A tissue that can contract to produce movement.Tendon A band of tissue that connects muscle to bone.Nervous System.Neurology: The study of the nervous system.Central nervous system (CNS): The brain and spinal cord.Peripheral nervous system (PNS): The nerves thatconnect the CNS to the rest of the body.Autonomic nervous system (ANS): The part of the PNS that controls involuntary functions such as breathing and digestion.Cerebrum The largest part of the brain involved in higher-level functions such as thought and language.Cerebellum A part of the brain that controls coordination and balance.Medulla oblongata A part of the brainstem responsible for vital functions such as breathing and heart rate.Neuron A nerve cell.Synapse The junction between two neurons.Cardiovascular System.Cardiology: The study of the heart and blood vessels.Artery: A blood vessel that carries blood away from the heart.Capillary: The smallest type of blood vessel.Heart: The organ that pumps blood throughout the body.Vein: A blood vessel that carries blood back to the heart.Aorta The largest artery in the body.Atrium A chamber of the heart that receives blood.Ventricle A chamber of the heart that pumps blood out.Blood pressure The force of blood against the walls of the arteries.Cholesterol A type of fat found in blood.Pulmonology: The study of the lungs and respiratory system.Bronchus: A large airway in the lungs.Diaphragm: The muscle that separates the chest cavity from the abdominal cavity.Larynx: The voice box.Lung: An organ that exchanges oxygen and carbon dioxide with the blood.Pharynx The throat.Pleura A membrane that lines the lungs and chest cavity.Trachea The windpipe.Gastroenterology: The study of the digestive system.Esophagus: The tube that connects the mouth to the stomach.Liver: An organ that produces bile and filters blood.Pancreas: An organ that produces digestive enzymes and hormones.Small intestine: The part of the digestive tract where most digestion and absorption occurs.Stomach: An organ that produces stomach acid and enzymes to begin digestion.Colon The large intestine.Rectum The final part of the large intestine.Anus The opening at the end of the digestive tract.Urinary System.Nephrology: The study of the kidneys.Bladder: An organ that stores urine.Kidney: An organ that filters waste products from the blood and produces urine.Ureter: A tube that carries urine from the kidneys to the bladder.Urethra The tube that carries urine from the bladder to the outside of the body.Endocrine System.Endocrinology: The study of hormones and the endocrine system.Adrenal gland: A gland that produces hormones that regulate stress and blood pressure.Hormone: A chemical messenger that travels through the bloodstream to target cells.Pancreas An organ that produces hormones such as insulin and glucagon, which regulate blood sugar levels.Pituitary gland A gland that produces hormones that control other endocrine glands.Thyroid gland A gland that produces hormones that regulate metabolism and growth.Integumentary System.Dermatology: The study of the skin.Dermis: The layer of skin beneath the epidermis.Epidermis: The outer layer of skin.Hair: A thin, thread-like structure that grows from the skin.Nail: A hard, protective covering on the fingertips and toenails.Sebaceous gland A gland that produces oil to lubricate the skin and hair.Sweat gland A gland that produces sweat to cool the body.Reproductive System.Gynecology: The study of the female reproductive system.Andrology: The study of the male reproductive system.Cervix: The lower part of the uterus that opens into the vagina.Fallopian tube: A tube that carries eggs from the ovary to the uterus.Ovary: An organ that produces eggs and hormones.Prostate gland A gland in males that surrounds the urethra and produces fluid that nourishes sperm.Testis: An organ in males that produces sperm and hormones.Uterus An organ in females that carries a developing fetus during pregnancy.Other Medical Terms.Diagnosis: The identification of a disease or condition.Etiology: The cause of a disease or condition.Epidemiology: The study of the distribution and patterns of health and disease in a population.Pathology: The study of disease processes.Prognosis: The predicted course and outcome of a disease or condition.Symptom: A subjective experience of a disease or condition, such as pain or nausea.Treatment: The management and care of a disease or condition.中文回答:与医疗相关的英语词汇。
inos的基因表达及其产物no在抗日本血吸虫感染免疫中的作用

华中科技大学博士学位论文iNOS的基因表达及其产物NO在抗日本血吸虫感染免疫中的作用姓名:***申请学位级别:博士专业:病原生物学指导教师:***2003.4.12003羁华中科技大学固济医学院蹲+学位论文iNOS的基因表达及其产物NO在抗日本血吸虫感染免疫中的作用华中科技大学同济医学院病原生物学系博士研究生龙小纯导师李雍龙全文摘要NO的合成有赖于一氧化氮合酶(NOS)的催化作用,机体内的NOS,有结构型一氧化氮合酶(cNOS)和诱导型一氧化氮合酶(iNOS)两类。
滇中,{iNOS在机体的免疫系统中具有重要的作用。
在感染性疾病的发生、发展过程中,iNOS催化生成的NO既可通过杀伤、抑制病原体发挥抗感染的作用,同时也参与对宿主免疫病理的调节。
因此,NO是当今生物学和医学领域中最热门的研究课题之一。
在寄生虫学领域,NO的研究也十分活跃。
不少资料表明,NO介导的细胞毒作用是机体抗寄生虫感染的重要方式,如NO可对刚地弓形虫、疟原虫和利什曼原虫产生杀灭作用,从而减轻或消除感染。
血吸虫病是一种严重威胁人类健康的寄生虫病,传统观念认为,抗体依赖的细胞介导的细胞毒作用(ADCC)是机体抗血吸虫感染的主要效应机制。
但近年来不少资料证明,在宿主抗曼氏血吸虫的免疫过程中,非特异性免疫效应也具有重要的作用。
体外试验证实NO对曼氏血吸虫童虫具有杀灭作用,而一些高效疫苗如’r射线照射尾蚴疫苗、需钙蛋白酶疫苗等对宿主保护力的产生与免疫后宿主肺部iNOS的高表达有关,提示NO介导的细胞毒作用也是机体的一种重要的抗感染方式。
因此,研究NO在机体抗血吸虫感染中的作用具有重要意义。
血吸虫引起的病理变化主要发生在肝脏。
沉积在肝脏中的虫卵引起肉芽肿反应,虫卵肉芽肿与纤维化的形成是肝脏病理变化的基础。
肝脏急性病变过程中局部升高的NO能通过多种途径对肝脏发挥保护作用,其中包括减轻由氧自由基引起的肝脏损伤,抑制由TNF一Ⅱ引起的肝细胞的坏死和凋亡,抑制血栓形成等。
微生物学与免疫学实验_厦门大学中国大学mooc课后章节答案期末考试题库2023年

微生物学与免疫学实验_厦门大学中国大学mooc课后章节答案期末考试题库2023年1.实验室用的紫外灯,其波长在260nm左右,照射时可以穿透玻璃等,因而可用于玻璃器械的灭菌。
参考答案:错误2.革兰氏染色出现假阳性的原因,可能是酒精脱色不足。
参考答案:正确3.枯草芽孢杆菌通过革兰氏染色法其结果是:参考答案:呈现蓝紫色4.酵母菌可进行有性和无性繁殖,其有性繁殖的有性孢子通常称为?参考答案:子囊孢子5.我们注射的新型冠状病毒疫苗,通常是抗体分子。
参考答案:错误6.动物免疫实验中,直接引起免疫反应的免疫原通常会选择()。
参考答案:蛋白质7.实验中的巨噬细胞是来源于()参考答案:小鼠腹腔8.酵母胞外多糖发酵时,活化酵母菌所用的培养基与发酵多糖时所用的培养基是不同的。
参考答案:正确9.实验中酵母菌胞外多糖的含量测定时采用的方法是()参考答案:苯酚-硫酸法10.酵母胞外多糖是水溶性的,分离时可加入()参考答案:80%的乙醇沉淀11.淀粉在酸的催化作用下,能发生水解;淀粉的水解过程中不正确的说法是:参考答案:呈蓝紫色者为阳性,红色为阴性。
12.细菌的菌落较小,且较少隆起。
参考答案:正确13.分光光度计与浊度计是不同的。
目前实验室一般用分光光度计来测量菌液的浓度。
参考答案:正确14.用噬菌体来清除细菌的方法,属于生物手段灭菌。
参考答案:正确15.培养放线菌的高氏一号培养基属于下列培养基中的:参考答案:合成培养基16.感冒季节带口罩防止感染,其原理是过滤除菌。
参考答案:正确17.在进行厌氧菌发酵时,下面哪个措施是不合理的()参考答案:静置培养,防止因搅拌引起空气混入18.两次划线之间,灼烧接种环的目的是参考答案:为了稀释接种。
19.为什么每次操作前都要点燃酒精灯?参考答案:因为要无菌操作。
20.在计算每克土壤样品的菌落数时一般选择,平板中的菌落数是多少的稀释度进行计算。
参考答案:介于30-30021.化学物质用于防止生物组织微生物生长时,一般称为?参考答案:防腐剂22.在菌落计数时,对应平板的菌落数是200,稀释1000倍,换算为每克土壤样品的菌落应该是?参考答案:20000023.在超净工作台进行接种时,哪项操作是正确的?参考答案:操作之前需要先用紫外灯对超净台进行灭菌处理。
分子生物学基础知识

素材聚合酶链式反应 PCR(生物学的聚合酶链反应)一般指聚合酶链式反应是一种用于放大扩增特定的DNA片段的,它可看作是生物体外的特殊DNA复制,PCR 的最大特点,是能将微量的DNA大幅增加。
由1983年美国Mullis首先提出设想,1985年由其发明了聚合酶链反应,即简易DNA扩增法,意味着PCR技术的真正诞生。
到如今2013年,PCR已发展到第三代技术。
1973 年,台籍科学家钱嘉韵,发现了稳定的Taq DNA聚合酶,为PCR技术发展也做出了基础性贡献。
PCR(聚合酶链式反应)是利用在体外摄氏95°高温时变性会变成单链,低温(经常是60°C左右)时引物与单链按互补配对的原则结合,再调至DNA聚合酶最适反应温度(72°C左右),DNA沿着磷酸到五碳糖(5'-3')的方向合成互补链。
基于聚合酶制造的PCR仪实际就是一个温控设备,能在变性温度,复性温度,延伸温度之间很好地进行控制。
真核生物的启动子由于真核生物中有三种不同的RNA聚合酶,因此也有三种不同的启动子,其中以启动子Ⅱ最为复杂,它和原核的启动子有很多不同:(1)有多种元件:TATA框,GC框,CATT框,OCT等;(2)结构不恒定。
有的有多种框盒如组蛋白H2B;有的只有TATA框和GC框,如SV40早期转录蛋白,(3)它们的位置、序列、距离和方向都不完全相同,(4)有的有远距离的调控元件存在,如增强子;(5)这些元件常常起到控制转录效率和选择起始位点的作用;(6)不直接和RNApol结合。
转录时先和其它转录激活因子相结合,再和聚合酶结合。
(一)Ⅱ类基因的启动子和调控区Ⅱ类基因的启动子由核心元件和上游元件组成。
核心元件包括TATA框和转录起始位点附近的启始子(initiator,Inr)。
亚克隆(英语:subcloning)是一种。
亚克隆:(subclone) 分为细胞克隆和。
该技术旨在将目的基因导入目标载体中,以进行进一步研究。
正常及异常之性别发展

正常及異常之性別發展區分及決定性別:1.基因性別2.性腺性別3.荷爾蒙性別4.內生殖器5.外生殖器6.腦部之性別(CNS or brain sex)7.後天指派決定之性別(Assignment or rearing sex)8.性別鑑定或性別表現正常發展建立基因性別受孕1. 性腺分化發展在5-6週,此時Primodial germ cell移行至gonadal ridges如果失敗則造成streak gonad,六週前為Bipotential(indifferent)的性腺(包含germ cells, special epithelial, mesenchyme and mesonephric duct,internal and sexternal genitalia undifferentiated)2. 接下來的分化由基因調控睪丸基因決定組(TDF gene)(SRY region of Y, sex determining region of the Y chromosome)對睪丸分化是必須的,如缺少TDF gene會造成gonadal dysgenesis TDF或SRY蛋白質基因對適當的性腺發展是需要的,3. 另外autosome gene (steroidogenic enzymes) 也是必須的睪丸的形成:6-7週: Sertoli cells, spermatogenic cords, seminiferous tubules, Leydig cells卵巢的發展:約於晚兩週發生Germ cells 於皮質層增生卵細胞20週時五到七百萬出生時只剩一到兩百萬,此時的卵細胞為prophase I在gonadal dysgenesis( 45X)則會有大量的atresiaAmbisexual embryo(八週)暫時並存有Wolfian( mesonephric) 及Mullerian( paramesonephric) ducts決定因素:AMH(MIF)及testosterone(由睪丸分泌)*AMH (anti-mullerian hormone): a member of the transforming factor-B family of glycoprotein differentiation factors that includes inhibin and activin.AMH(由Sertoli cells合成)八週時可造成單側Mullerian tube regression抑制oocyte meiosis促使睪丸下降AMH可作為一種serum marker去辦別testicular tissueTestosterone:由Leydig’s cells分泌,促使單側wolfian duet分化成epididymus, vas deferens and seminal vesicles, ejaculatory ducts局部paracrine作用:adjacent gonad內部的傾向去feminize缺乏AMH-->輸卵管,子宮,陰道上部之發育缺乏testosterone: Wolfian system退化Bipontenal(未分化) stage(6週):neutral primordial:可發育成男性或女性外生殖器包括A genital tubercle, a urogenital sinus, two labioscrotal swellings決定因子:由Leydig cells來的Androgen在目標組織以5 -reductase把testerone(T)變成dehydrotesterone(DHT)男性化(Masculization):九到十四週MALE:陰莖,陰囊,penile urethra 或FEMALE:陰蒂,大陰唇,小陰唇,陰道下段Abnormal androgen inpact: varible external ambiguityAndrogen 編輯CNS男性行為的潛能社會的interactiongender role is heavily influenced by assignment of sex of rearing followed by social interaction based upon genital appearance and the development of secondary sexual characteristics.A. 胎兒內分泌的異常(disorders of fetal endocrinology)Masculinized females( female pseudohermaphroditism)1. Congenital adrenal hyperplasia21-hydroxylase( P450c21) deficiency11β-hydroxylase(p450c11β) deficiency3β-hydroxysteroid dehydrogenase deficiency2. Elevated androgens in the maternal circulationDrug intakeMaternal disease3. Aromatase( P450arom) deficiencyIncompletely masculinized males( male pseudohermaphroditism)1. Androgen insensitivity syndromes2. 5 α-Reductase deficiency3. Testosterone biosynthesis defects3β-hydroxysteroid dehydrogenase deficiency17α-hydroxylase( p450c17) deficiency17 β -hydroxysteroid dehydrogenase deficiency4. Gonadotropin resistant testes5. Anti-mullerian hormone deficiencyB. 異常性腺發展( disorders of gonadal development)Male pseudohermaphroditismPrimary gonadal defect-Swyer syndromeAnorchiaTrue hermaphroditismGonadal dysgenesisTurner syndromeMosaicismNormal karyotyper—Noonan syndromeFemale Pseudohermaprodites:(女性假陰陽人)Karyotype為46XX之女性,雖有卵巢,但沒有正常的女性外生殖器先天性腎上腺過度增生CAH(Congenital adrenal hyperplasia)男性化的外生殖器Masculinized external genitalia, varying degree過量的androgen被腎上腺皮質(adrenal cortex)製造(12週)可與代謝異常(salt wasting or hypertension)一起表現1.21-hydroxylase deficiency (adrenal only)A.為CAH最常見的一種(90%)B.症狀a.鹽類缺乏(salt wasting)b.simple virilizingte onset(nonclassic, attenuated, acquired):在青春期或之後才出現多毛症(Hirsutism),月經問題及不孕(mild/mild or mild/severe)d.Cryptic form:asymptomatic(normal/mild or normal/severe)C.自體隱性D.第六對染色體CYP21B gene的突變Allelic variants: normal, mild, severeHomozygous or heterozygous典型的病人:1/14000 births帶原者:1/100 Caucasians非典型的病人:1/30-1000帶原者:1/3-14(大多數為自體隱性)E.診斷:血中17-OHP(正常值的50-400倍)Baseling(早晨):noraml<200ng/dl200-800ng/dl需要ACTH stimulation test>800ng/dl:確定診斷F.治療:hydrocortisone(10mg/day)&9-fluorohydrocortisone(100ug/day),cortisol12-18mg/m2 or prednisolone 3.5-5mg/m2Monitoring: 17-OHP(500-4000ng/dl),ASD,T,PRA(lower limit of normal)外科治療:陰蒂切除(前幾年)陰道重建(青春期後)在重大壓力下給予額外的支持,如手術,妊娠,分娩過度治療會引起Cushing’s syndromeG..產前診斷:在羊水中升高的ASD絨毛膜取樣DNA probes(可在critical period前給予治療)產前治療:Dexamethasone(有顯著的母體副作用),只有1/8之胎兒需治療在新生兒時密切觀察adrenal insufficiency2.11 β -hydroxylase deficiency(adrenal only,5-8%)男性化(virilization),,高血壓,volume overload,hyperkalemic alkalosis自體隱性,位於染色體第八對上,有mild form存在診斷:high DOC & 11-deoxycortisol, low PRA(plasma rennin activity)產前診斷:羊水中11-deoxycortisol升高3.3 β -hydroxysteroid dehydrogenase deficiency(adrenal and ovary)降低glucocorticoid, mineralocorticoid, adndrogens and estrogensSevere form:極少存活Mild form:普遍、輕度多毛、DHEA升高自體隱性診斷:DHEA及DHEAS顯著升高4.17 α -hydroxylase deficiency( adrenal and estrogens)curtailed synthesis of cortisol,androgens and estrogens高血壓,低血鉀,infantile female external genitalia,原發性無月經(FSH和LH 升高),ambiguity in male第十對染色體5.20-22 desomolase deficiency( adrenal and ovary):致命的6. 母體循環中androgen升高1.Maternal androgen secreting tumor2.progestin 或danazol攝取surgical correction for external genitalia is theonly indicated treatment3.Placental aromatase deficiency: DHEA or DHEAS loading test男性假陰陽人(Male psydohermaphrodites)1.雄性素不敏感症候群(AIS:androgen insensitivity syndrome)完全的雄性素不敏感/TF(testicular feminization)女性表型(female phenotype);46XY性聯隱性,1/3沒有家族史正常AMH活性:睪丸下降至inguinal ring睪丸正常發育,Testosterone 正常或輕微上升在青春期時乳房正常發育,但原發性無月經稀少或缺乏腋毛及陰毛短的,盲端的陰道,子宮,卵巢是缺乏的高的LH,E2FSH正常或升高10%患者有原發性無月經症兒童如有腹股溝疝氣或腹股溝腫塊需懷疑TFgonadal tumor的發生(overall incidence 5%)相當晚,很少在25歲前性腺切除(gonadectomy)需在青春期後實施(大約16-18歲)2.不完全雄性素不敏感/TF(testicular feminization)性聯隱性,雄性素接受器基因突變(q11-12 of X)臨床表現範圍從完全男性化的失敗到完全以男性表現均有包括陰蒂肥大(clitoromegaly),陰唇黏合(labial fusion)genital ambiguity, 嚴重的精子過少或無精症,undervirilized fertile male如果病人之前被當成女性教養,必須行gonadectomy以防止惡性病變如Reifenstein syndrome(病人之前被當成男性教養),女性化(feminization),男性女乳症(gynecomastia)會在青春期後發生他們會不孕且不會對exogenous androgen反應High testerosterone, mild elevated LH, high E2, normal to elevated FSH3.5 -reductase deficiency/PPH( pseudovaginal perineoscrotal hypospadia)自體隱性正常wolfian duct virilization(男性化), 但對於DHT dependent的構造:外陰,前列腺,尿道出生時,陰蒂肥大,嚴重的會陰尿道下裂,薦骨裂(scrotal cleft, failure of fusion of labioscrotal folds), 持續的urogenital opening( separate urethral and vaginal openings), underdevelopment of vagina男性化發生在青春期,此時女性會變成男性較少的體毛,較少的顳部退縮,無ance正常的spermatogenesis,男性性慾(male libido)及muscle mass,聲音低沈診斷:elevated T/DHT ratio, especially after HCG stimulationgonadectomy以防止惡性病變及virilization(男性化)自體隱性可分五種enzyme之缺陷1.P450scc,2.3 β -OH dehydrogenase3.17 α -hydroxylase4.17-20desmolase5.17 β -OH dehydrogenase前三種可能會adrenal failure 和死亡17 β -hydroxysteroid dehydrogenase deficiency男性內生殖器,沒有mullerian構造出生時有女性外生殖器,睪丸則位於inguinal canal會在青春期男性化,或女性化(feminization)及男性女乳症(gynecomastia)診斷:low testosterone 及升高的前驅物(如ASD,estrone)如當成女性教養需early gonadectomyGonadotropin resistant testesLeydig cells退化或異常分化降低LH/HCG的反應接受器功能或接受器後成分缺陷基本上是女性,但曖昧不明(ambiguous)生殖器,male cryptorchid testes(隱睪) with degenerated Leydig cells, no mullerian duct, present vas and epididymis Gonadotropin升高AMH defects( uterine hernia syndrome)性聯隱性或自體隱性AMH功能失常正常可生育男性但有mullerian structures在inguinal hernia sac不正常性腺生成(abnormal gonadogenesis)Primary gonadal defects原始性腺缺損( Testicular regression syndrome)1. Swyer syndrome( embryonic testicular regression)睪丸在生殖器分化前沒有繼續發育或已退化XY karyotype但有正常女性之內外生殖器原發性無月經,青春期缺乏第二性徵的發育Fibrous band areas移除,接著給予荷爾蒙補充(HRT)2. 無性腺(Agonadism),睪丸發育不良testicular dysgenesis ( fetal testicularregression)曖昧不明(ambiguous)的外生殖器,both internal ducts的殘跡外科移除streaks3. 無睪畸形Anorchia, vanishing testis曖昧不明(ambiguous)的男性外生殖器,有male wolffian ducts缺少mullerian ducts, no detectable 睪丸,smaller phallus真陰陽人(True hermaphrodites)同時擁有卵巢及睪丸組織包含在一個gonad(ovotestis) 或一側是卵巢,一側是睪丸組織內在的性器官與鄰近的gonad相符曖昧不明(ambiguous)的外生殖器但有足夠的男性特徵3/4有男性女乳症(gynecomastia)1/2青春期後有月經60%XX, few are XY其餘的為mosaics with XX lineGonodal dysgenesis(性腺發育不良)兩側殘餘的是streak gonadsTurner syndrome有一個不正常的X染色體或是缺少一個X染色體1/2000-5000活產的女嬰(98%流產)Phenotypic female,身高不高(142-147cm),sexual infantilismStreak gonads composed of white fibrous stroma with no ova or follicles鰭狀頸(webbed neck),high arched palate, 手肘外翻(cubitus valgus)盾狀胸(broad shieldlike chest),低髮線(low hair line)short fourth metacarpal bone, 短腿(short leg),腎畸形(renal anormalities; horseshoe kidney, pelvic kidney, rotational problem, duplication of collecting system)自體免疫問題,胰島素抗性(insulinresistence),聽力喪失(healing loss)心血管問題(cardiovascular abnormalities; bicuspid aortic valus, coarctation of aorta, mitral value prolapse, aortic aneurysms),肢體淋巴水腫(lymphedema of extremities at birth)正常智力通常直到青春期方被診斷篩檢:甲狀腺功能,抗體,IVP,超音波,心臟超音波,聽力檢查,lipid profile ,糖類代謝,週期骨盆腔檢驗去排除性腺的惡性病變如有月經或生育能力則因為mosaic complement如乳房或sexual hair自行發育,必須懷疑gonadal neoplasiaPure gonadal dysgenesis46XX:早發性的卵巢退化(streak gonads),無turner stigma自體隱性46XY:正常女性內生殖器,輕微陰蒂肥大minimal乳房發育,缺乏turner表徵(stigma)menstrual function suggests tumor development有gonadal tumor的risk:15-30%: gonadoblastoma,dysgeminoma,embryonal carcinoma早期就需移除腹腔內的gonad,並保留輸卵管,子宮Yp( SRY)deletion or loss of functionPartial gonadal dysgenesis46XY:有部分testicular development, 曖昧不明(ambiguous)的生殖器Mixed gonadal dysgenesis45X/46XY 最常見一側為streak gonad,一側是發育不良或正常的睪丸Ductal develop與同側的gonad相符Phenotype可從從曖昧不明(ambiguous)的生殖器到正常男女的phenotype且有streak gonads大多數身材矮小,1/3有turner stigma有gonadal tumor的發生率為25%外科移除gonadal tissue1.適應症:gonadal tissue with any Y components2.儘速移除,除非complete AI(青春期後再做)3.以腹腔鏡處理,嘗試保留子宮及輸卵管沒有卵巢組織病人的荷爾蒙補充治療以女孩養育以unopposed estrogen(0.3mg premarin or 0.5mg E2 QD)於10歲左右開始補充持續六個月到一年,接著改用sequential regimen(0.625mg premarin or 1.0mg E2 QD 和10mg provera for 12 days each month)身材矮小的病人( 如turner syndrome),ERT應直到bone age為11-12才開始以避免epiphysial closureGrowth hormone treatment yields significant growth for at least 6 years( achieving adult height of over 150cm)合併低劑量動情素和recombinant GH為一最佳組合1.首要的診斷需先排除CAH2.親屬的病史3.理學檢查a.是否可觸摸到gonad? 如在inguinal regions或scrotal folds發現gonads大多為睪丸b.陰莖(phallus)徑及長度?新生兒clitoris長度小於1cm,正常陰莖長介於2.8-4.2公分c.尿道口位置what is the position of uretral meatus?from hypospadia tourogenital sinus? to what degree are the labiosacral folds fused?posteriorfusion or bifid scrotum?Is there a vagina,vaginal pouch or urogenitalsinus? Is there a uterus? Hyperpigmentation? Dehydration?Hypotension,hypertension? Turner stigma?b:a.Pelvic USG &sinusographyb.Karyotypec.Electrolyted.Androgen(ASD/T/DHEA/DHEAS),17-OHP,11-deoxcortisol,11-deoxycorticosteronee.ACTH stimulation test, HCG stimulation test5.鑑別診斷由palpable gonads和uterus的有無,karyotype可將病人分為四大類a.Female pseudohermaphroditism(FP)b.Male pseudohermaphroditism(MP)c.True hermaphroditism(TH)d.Gonadal dysgenesis(GD)FP:臨床症狀adrenal failure顯示adrenal enzyme缺乏高血鉀(hyperkalemia) and 低血鈉(hyponatremia):aldosterone deficiency高血壓&低血鉀:elevated deoxycorticosteroneAndrogen and 17-OHP可幫助鑑別診斷Elevated 17-OHP:21-hydroxylase deficiencyElevated 11-deoxycorticosterone/deoxycortisol:11 β -hydroxylase deficiency Elevated DHEA with normal 17-OHP:3 β -OH dehydrogenase deficiencyNo measurable cortisol/androgen precursors:P450sec deficiencyElevated progesterone:P450c17 deficiencyElevated ASD/DHEA:17 β -OH dehydrogenase deficiencyUnresponsive to HCG stimulation: Leydig cell hypoplasiaElevated T/DHT after HCG stimulation: 5 α -reductase deficiencyNormal ACTH/HCG stimulation: androgen insensitvity開腹探查的適應症1.46XX,且有曖昧不明(ambiguous)的生殖器,正常的男性荷爾蒙(androgen): TH or mixed GD(gonadectomy is indicated)2.46XY,且有曖昧不明(ambiguous)的生殖器,正常的男性荷爾蒙(androgen),沒有可觸摸到的性腺(gonad): imcomplete AI,5a-reductasedeficiency, TH or mixed GD 照女性養育,且行gonadectomy兩側性腺切片檢查或切除(gonadectomy)已確定TH或GD的診斷後來性別的分派(assignment of sex of rearing)1. 有次要男性特徵的女性需當女性養育2. 下列的男性需當男性養育a. isolated hypospadiab.isolated 隱睪症(cryptorchidism),已修補c.有uterine hernia syndrome的男性所有其他的病人需節育(sterile)18個月時可再分派外生殖器重建需在18個月前施行socialization and hormonal therapy are important for gender identity。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
The Mouse Testis Is the Source of Various SerineProteases and Serine Proteinase Inhibitors (SERPINs):Serine Proteases and SERPINs Identified in Leydig Cells Are under Gonadotropin RegulationFanny Odet,Ade ´lie Verot,and Brigitte Le Magueresse-BattistoniInstitut National de la Sante ´et de la Recherche Me ´dicale,Unite ´418,Institut National de Recherche et de Se ´curite ´Unite ´Mixte de Recherche 1245,and Universite ´Lyon 1,Hopital Debrousse,69322Lyon cedex 05,FranceThe occurrence of various serine proteinases and serine pro-teinases inhibitors (SERPINs)was investigated by RT-PCR in whole testes of 1-,3-,and 8-wk-old mice in crude and enriched germ cell fractions,mouse Leydig tumor cells (mLTC-1),and primary cultures of 3-and 8-wk-old enriched fractions of Ley-dig cells and 3-wk-old Sertoli cells.New members were iden-tified in the testis protease repertoire.Within the Leydig rep-ertoire,a PCR product was found for plasminogen activators urokinase plasminogen activator (uPA)and tissue plasmino-gen activator (8-wk-old cells),matriptase-2(mLTC-1),kal-likrein-21,SERPINA5,SERPINB2(primary cultures),and serine peptidase inhibitor Kunitz type 2(SPINT2).The go-nadotropin regulation was explored by semiquantitative RT-PCR,using steroidogenic acute regulatory protein (StAR)as a positive control.Matriptase-2,kallikrein-21,SPINT2,and SERPINA5were down-regulated,whereas uPA and its recep-tor were up-regulated by human chorionic gonadotropin (hCG)via cAMP in the mLTC-1cells.Positive effects were observed transiently after 1–8h of hCG exposure,and nega-tive effects,first evidenced after 6h,lasted 48h.The hCG-induced effects were confirmed in primary cultures.In addi-tion,SERPINB2was augmented by hCG in primary cultures.Addition of either trypsin or protease inhibitors did not alter the hCG-induced surge of StAR.Because hCG regulated pro-teases and SERPINs (whereas testosterone did not),it could alter the proteolytic balance of Leydig cells and consequently the metabolism of extracellular matrix components.There-fore,even though a direct interplay between the early hCG-induced surge of uPA and StAR is unlikely,our data to-gether with the literature suggest that extracellular matrix proteins alter Leydig cell steroidogenesis.(Endocrinology 147:4374–4383,2006)ANUMBER OF important processes that regulate the activity and fate of many proteins are strictly depen-dent on proteolytic processing events.The serine proteinase family is one of the oldest characterized and largest families of proteolytic genes (227members in the mouse)(1,2),which has well-characterized roles in diverse cellular activities in-cluding blood coagulation,platelet activation,fibrinolysis and thrombolysis,extracellular matrix (ECM)remodeling,and cancer invasion (3).The serine proteinases can be further subdivided into 16families,among them the plasminogen activators,transmembrane serine proteinases,and kal-likreins.Serine proteinase activity is regulated by serine pro-teinase inhibitors (SERPINs).The SERPINs belong to an ex-panding superfamily of structurally similar but functionally diverse proteins,and most of them share a substrate suicide mechanism irreversibly inactivating the SERPINs (4–6).The testis is a reproductive organ that serves two decisive functions,the production of spermatozoa taking place in the seminiferous tubules and the synthesis and secretion of tes-tosterone by the Leydig cells located in the interstitium.Spermatogenesis is hormonally regulated,pituitary gonad-otropins positively regulating Leydig and Sertoli cell secre-tions through LH and FSH,respectively.Testosterone,pro-duced as a result of LH action on Leydig cells,acts via androgen receptors localized on Sertoli,peritubular,and Leydig cells.Sertoli cells play several key roles in spermat-ogenesis.They are targets for FSH and testosterone,these hormones being responsible for the initiation and mainte-nance of spermatogenesis.Moreover,together with the peri-tubular cells,they also form the cytoarchitectural scaffolding of the tubule,providing structural and nutritional support for the developing germinal cells (7–10).In an attempt to elucidate the role of proteinases and proteinase inhibitors in testicular physiology,we examined the presence of various serine proteinases and SERPINs in the whole testes of mice as well as isolated testicular cells.For this purpose,we used total RNA recovered from whole testes of 1-,3-,and 8-wk-old mice,from crude and enriched germ cell fractions,primary cultures of 3-wk-old Sertoli cells,3-and 8-wk-old enriched preparations of Leydig cells,and mouse Leydig tumor cells (mLTC-1).Because Leydig cells were found to express several proteinases and SERPINs,we determined whether they were under gonadotropin regula-tion.We also examined the influence of testosterone.First Published Online June 1,2006Abbreviations:aPC,Activated protein C;ECM,extracellular matrix;hCG,human chorionic gonadotropin;HGFA,hepatocyte growth factor activator;HPRT,hypoxanthine phosphoribosyl transferase;mLTC,mouse Leydig tumor cell;PA,plasminogen activator;PC,protein C;PCI,protein C inhibitor;SERPIN,serine proteinase inhibitor;SPINT1or 2,serine peptidase inhibitor Kunitz type 1or 2;StAR,steroidogenic acute regulatory protein;tPA,tissue plasminogen activator;uPA,urokinase plasminogen activator;uPAR,uPA receptor.Endocrinology is published monthly by The Endocrine Society (),the foremost professional society serving the endocrine community.0013-7227/06/$15.00/0Endocrinology 147(9):4374–4383Printed in U.S.A.Copyright ©2006by The Endocrine Societydoi:10.1210/en.2006-04844374Materials and MethodsAnimals,tissues,and cell preparationsCD-1mice were purchased from Elevage Janvier(Le Genest,France). Testes were collected from1-,3-,and8-wk-old mice.Enriched prepa-rations of pachytene spermatocytes and early spermatids(75–80%en-richment)were obtained after centrifugal elutriation of a crude germ cell preparation recovered from adult mice testes by trypsination(11).Once harvested,testes or cells were immediately stored atϪ70C and pro-cessed for RNA analysis.Experiments were conducted according to the Guide for the Care and Use of Laboratory Animals.Leydig-enriched fractions and Sertoli cells were isolated from3-wk-old mice testes and cultured in Ham’s F12-DMEM(Life Technologies, Grand Island,NY)at32C in a humidified atmosphere of5%CO2as previously described(12),except that a hyaluronidase treatment(0.1%, 20min,32C)was introduced after the second collagenase digestion to reduce peritubular cell contamination in the Sertoli cell fraction(13). Leydig cells were recovered in the supernatant of the first collagenase digestion,and the resulting suspension was hypotonic treated to elim-inate the contaminating germ cells,as described recently(14).After several washes,the cell suspension was plated in12-well plates(50,000 cells/well).Enrichment of the cell suspension was higher than80%as judged by3-hydroxysteroid dehydrogenase immunostaining(not shown).At the end of the enzymic procedure,the Sertoli cell suspension was washed with fresh culture medium,and cells were seeded in6-well plates at a ratio of1ϫ106viable cells/well in Ham’s F12-DMEM.They were cultured for2d.At that time,the purity of the cultures was higher than90%,and contamination was mainly due to residual germ cells(an average of5–7%)(not shown).Leydig-enriched fractions were also isolated from8-wk-old mice testes and cultured in Ham’s F12-DMEM at32C in a5%CO2incubator as described for the3-wk-old testes.They were recovered in the super-natant of the first collagenase digestion,and the resulting suspension was harvestly washed,filtered through a45-mm nylon mesh and hy-potonic treated.After several washes,the cell suspension was plated in 12-well plates(50,000cells/well).Enrichment of the cell suspension examined on the next day was higher than70%as judged by3-hy-droxysteroid dehydrogenase immunostaining(not shown).Cell line culturesThe immortalized Leydig cell mLTC-1line was kindly provided by D.M.Stocco(Texas Tech,Lubbock,TX).The mLTC-1cells were culti-vated at37C in a5%CO2incubator.Culture medium was a RPMI1640 medium(Sigma-Aldrich Corp.,St.Louis,MO)supplemented with10% fetal calf serum until cells reached subconfluency(70%),as described (15).Serum was then omitted,cells were rinsed abundantly,and fresh medium was replaced.Cell treatmentIn the relevant experiments,testosterone(0.1m),human chorionic gonadotropin(hCG;from1to100ng/ml;Organon,Puteaux,France), bu2cAMP(1m m),actinomycin D(5g/ml),cycloheximide(50g/ml), trypsin(from1to1000ng/ml),or proteases inhibitors(a cocktail of aprotinin and leupeptin at100m each)(all from Sigma)were added to the cultures at the doses and for the time periods indicated.RNA extraction,RT-PCR,and semiquantitative RT-PCR Procedures for RNA extraction and RT-PCR have been described elsewhere(16).Specific primers were designed using the Gene-Jockey sequence processor(Biosoft,Cambridge,Cambridgeshire,UK),and the optimal temperature of annealing was defined for each couple of prim-ers(Table1).Negative controls contained water instead of cDNA.PCR with no reverse transcription gave no product,eliminating the possi-bility of a genomic DNA contamination in the RNA preparations.Am-plified cDNAs were visualized in a1.5%agarose gel stained with ethidium bromide.A DNA ladder(Promega,Charbonnie`res,France) was loaded on each gel,and18S was used to ensure equal loading.PCR products were sequenced by Biofidal(Lyon,France).Conditions for reliable semiquantitative RT-PCR were optimized for each series of primers in the presence of␣-33P dATP(0.75Ci;2500Ci/mmol;Am-ersham Pharmacia Biotech Europe GmbH,Orsay,France),as described elsewhere(17,18).The PCR products were separated on8%polyacryl-amide gel electrophoresis in1ϫTris borate EDTA(TBE)buffer.Gels were transferred to filter paper,dried,and exposed to Kodak biomax MR1films(Sigma).The band densities were determined by scanning densitometric analysis(Scion image,4.03;Scion Corp.).Densitometry data were normalized using hypoxanthine phosphoribosyl transferase (HPRT).Protein extraction and analysisGonadal proteins were extracted in PBS containing1%Nonidet P-40 and5m m EDTA,as previously described(16).For plasminogen zy-mography,10-fold concentrated proteins were electrophoresed at4C on 10%PAGE in the absence of any reducing agent.After electrophoresis, sodium dodecyl sulfate was removed from the gel by exchange in Triton X-100(two washes,30min each,at room temperature in2.5%Triton X-100,followed by three washes,30min each,in distilled water).The gel was subsequently placed on a casein-agar-plasminogen underlay asTABLE1.Nomenclature and selected information on the serine proteinases and SERPINs hereby studied(1)Nomenclature Selected information Ref. Serine proteinasesHGFA Activates the conversion of proHGF into active HGF20 Hepsin Transmembrane serine proteinase which may also activate proHGF21 Kallikrein-21Specifically expressed in Leydig cells in testis where it degrades at least fibronectin22 Matriptase-2Transmembrane serine proteinase showing degrading activity againsttype I collagen and fibronectin23 PAtPA uPA Catalyse the conversion of plasminogen into plasmin,a serine proteinase with alarge spectrum of activity toward latent proteinases and ECM components3aPC Anticoagulant previously identified in the testis24Targeted proteinases among those studiedSERPINsHGFA inhibitor(HAI)SPINT1(HAI-1)HGFA,matriptase-2,hepsin20–23 SPINT2(HAI-2)HGFA,kallikrein,hepsin and plasmin,but not uPA25–27 PA inhibitor(PAI)SERPINE1(PAI-1)uPA,aPC,tPA,plasminSERPINB2(PAI-2)uPA,tPA(poor inhibitor)SERPINA5(PAI-3or PCI)aPC,uPA,tPA,kallikrein3–6 SERPINE2(Protease nexin1,or PN-1)uPA,tPA,plasminOdet et al.•Serine Proteinases,Serpins,and Mouse Testis Endocrinology,September2006,147(9):4374–43834375previously described(18,19).Plasminogen-degrading activity was vi-sualized after incubation at37C for12h,and gels were scanned. SDS-PAGE(10%)and Western blotting were carried out as described elsewhere(16–18),using the concentrated culture media also assayed in plasminogen zymography.A rabbit polyclonal antibody was used against recombinant mouse protein C inhibitor(PCI or SERPINA5;di-lution1:1000;a gift from M.Geiger,Department of Vascular Biology and Thrombosis Research,University of Vienna,Vienna,Austria)and was detected by an antirabbit IgG(dilution1:10,000)conjugated to peroxy-dase(Jackson ImmunoResearch,Baltimore,MD).Precision protein stan-dards(Bio-Rad Laboratories,Hercules,CA)were loaded for estimation of the molecular masses of the bands,which were revealed using an ECLϩchemiluminescent detection system(Amersham Pharmacia Biotech).Data analysisThe densitometric data are given as the meanϮsem(nϭ3–4),and experiments were repeated at least three times(twice for the8-wk-old preparations of Leydig cells).The significance of the results was deter-mined by ANOVA followed by a Mann-Whitney U test.Differences were considered significant at PϽ0.05.ResultsRT-PCR screening of serine proteinases and SERPINs Selected information and nomenclature for the seven serine proteinases and six SERPINs studied are summarized in Table1,and the list and sequences of the designed specific primers for PCR studies are described in Table2.Total RNA was recovered from1-,3-,or8-wk-old testes from total germ cells or enriched fractions in pachytene spermatocytes or early spermatids;the mLTC-1;Leydig-enriched fractions re-covered from3-and8-wk-old mice testes;and3-wk-old Sertoli cells,which had been cultured for2d in basal con-ditions.A PCR product of the right size and sequence(not shown)was detected for each of the serine proteinases and SERPINs(Fig.1).Plasminogen activators(PAs)were among the most abundant serine proteases within the testis at the three ages investigated,and tissue plasminogen activator (tPA)was more abundant than urokinase plasminogen ac-tivator(uPA).SERPINA5,serine peptidase inhibitor Kunitz type1(SPINT1),and SPINT2were the most abundant SERPINs within the testis.Germ cells had the smallest rep-ertoire with hepatocyte growth factor activator(HGFA),ac-tivated protein C(PC),SERPINA5,SPINT1,and the longest form of SPINT2.The weak bands seen for tPA and SERPINE2 in the nonelutriated fraction probably resulted from a so-matic contamination because they were not detected in the enriched fractions(Fig.1).These data extend previous results showing activated PC(aPC)in mouse germ cells(24)and SPINT2in human germ cells(27).Primary cultures of Leydig-enriched fractions as well as mLTC-1cells exhibited a PCR product for six of the13serine proteases and SERPINs investigated,including the two plas-minogen activators,matriptase-2,kallikrein-21,SERPINB2, SERPINA5,and SPINT2.No signals were seen with primers designed against activated protein C,HGFA,or hepsin(Fig.1).Interestingly,the PCR band for matriptase-2was detected in mLTC-1but not Leydig-enriched fractions,Sertoli cells,or germ cells.Thus,the origin of the weak band in whole testes is yet unknown.Inversely,a PCR band for SERPINB2was found in Leydig-enriched fractions but not mLTC-1cells. Finally,a PCR band for tPA was found in8-wk-old enriched fractions of Leydig cells(Fig.1).All these data on Leydig cells are original except for tPA(28)and kallikrein-21(22).Sertoli cells exhibited stronger PCR products corresponding to uPA and tPA than Leydig cells.A weak PCR product correspond-ing to hepsin was also found in Sertoli cells.Regarding the SERPINs,Sertoli cells exhibited a PCR product for each of them.In addition,PCR products were stronger in Sertoli cells than Leydig cells,with the exception of SERPINB2(Fig.1). Addition of hCG altered the expression of proteinases and SERPINs in the mLTC-1cellsLeydig mLTC-1cells were cultured to80%confluence, serum starved,and then treated with hCG at1,10,or100 ng/ml for6h.Cells were then scraped,total RNA was extracted,and RT-PCR experiments performed.PrimersTABLE2.List and sequence of the designed specific primers for PCR studiesAccession no.Primers(5Ј–3Ј)Size(bp)T Opt(C) Sense AntisenseHPRT J00423CCTGCTGGATTACATTAAAGCACTG GTCAAGGGCATATCCAACAACAAAC35465 18S X00686GGAATAATGGAATAGGACCG TCTGTCAATCCTGTCCGTGTCC43561 StAR L36062GCATACTCAACAACCAGGAAGG CTGGTTGATGATTGTCTTCGGC51166 AR NM_013476TACATGTGGTCAAGTGGG TGTGTGGAAAATAGATGGG51166 Serine proteinases and receptor for uPAuPA NM_008873TGTCAGAACGGAGGTGTATGCG TGTTCTTCTGGTAGATGGCTGC50765 uPAR X62700GAATGGCAAGATGATAGAGAGC AACACTGGAAGCCATTCGGTGG48969 tPA J03520TATTGTCGGAATCCAGATGG AACGAACCTGACACTGGAGTCG46163 Matriptase-2AY240929CTCTCTGGACTACGGCTTGGCGCTC TGGAGGCCACAGTCACAGTGTTGC59665 Hepsin NM_008281TCATCTCTGTATGTGACTGTCC TAGAGAGGTGGACCAAGGCAA39565 HGFA AF224724ACTTCTTCAACCGCACCACG CTACTACGGTATGTCCATTCGG45766 Kallikrein-21NM_010642GAACCTGGACACCTGTTACC CGTAGTAACATCAGGTCATTGC39666 aPC NM_008934CCAAGGATAGTCAACGGAACGC CTGCCCATCCTTTGATTCTGTCGC43366 SERPINsE1M33960CCAACAAGAGCCAATCACAAGG GAAAGGTGGAGACTCTTC50363 B2NM_011111TCCTTGAATGTGCTGAAGAAGC GACCACAACATCATCTTCATCC45169 A5AH006766ACAACTATGTAGCCAAGCAGACC TCCTCCACCTGCTTCATCTTGC32465 E2NM_009255TGAAGTCAGTGAAGATGGAACC CCTGCTCATCCTTCACTACAGC46458 SPINT1AF099018TGACTATCACTGTGCTAACTGC TAGGAAGAACCTCTACGGTGCC59265 SPINT2AF099016AATGGAGCCGACTCTTCTGTCC CTACTCCGTCTGGTATCTCC35665The optimal temperature(TOpt )for annealing,the size of the expected PCR fragments,and the source for the design of the primers arereported.The number of cycles was determined for each set of primers.It ranged from19to26.4376Endocrinology,September2006,147(9):4374–4383Odet et al.•Serine Proteinases,Serpins,and Mouse Testisused included those specific for uPA,kallikrein-21,matriptase-2,SPINT2,SERPINA5,HPRT as a house keeping gene,and the steroidogenic acute regulatory protein (StAR)to ensure that Leydig cells responded to hCG under our experimental conditions.Addition of hCG resulted in a sig-nificant enhancement of StAR at the three doses,and 100ng/ml induced a 2.5-fold increase (P Ͻ0.05).Interestingly,hCG positively regulated the expression levels of uPA and down-regulated the expression levels of matriptase-2,kal-likrein-21,SERPINA5,and SPINT2(Fig.2).These effects depended on the doses of hCG,and a significant (P Ͻ0.05)effect was obtained with the dose of 100ng/ml.Indeed,uPA levels increased 4.2-fold,whereas levels of kallikrein-21,matriptase-2,SPINT2,and SERPINA5were halved in the hCG-treated cultures,compared with the untreated cultures.Gonadotropins positively regulate the expression of uPA,its receptor (uPAR),and the uPA enzymatic activity via cAMPThe addition of hCG at a dose of 100ng/ml for 2h,which significantly increased (2.5-fold increase;P Ͻ0.05)the ex-pression of StAR,also significantly enhanced (a 5.2-fold in-crease;P Ͻ0.05)the expression of uPA (Fig.3).The hCG-induced expression of uPA was maintained after 8h (a 2-fold increase;P Ͻ0.05),but it was no longer observed after 24h of stimulation.The time-course effects of hCG were mirrored by the addition of bu 2cAMP 1m m ,indicating the involve-ment of the protein kinase A (Fig.3A).We next examined the expression levels of the uPAR because uPAR dictates the site and extent of proteolysis of uPA (3).Addition of hCG or bu 2cAMP was found to exert a significant but transient stim-ulatory effect on the expression of uPAR.The effect was observed after 2h (a 3-and 2.9-fold increase,respectively;P Ͻ0.05)but not after 8or 24h of stimulation (Fig.3A).The role of transcription and ongoing protein synthesis in the hCG-induced uPA mRNA levels was evaluated.For this purpose,mLTC-1cells were pretreated for 30min with ac-tinomycin-D or cycloheximide and stimulated with hCG 100ng/ml for 6h.The results indicate that the presence of the inhibitor of either RNA or protein synthesis abolishes the hCG-induced positive regulation of uPA and StAR (Fig.3B).The biological activity of uPA was examined by zymog-raphy in culture media from mLTC-1treated for 24h with hCG or bu 2cAMP.We observed a strong enhancement of the uPA lytic band in the stimulated cells.No tPA lytic band was detectable (Fig.3C).Gonadotropins negatively regulate the expression of matriptase-2,kallikrein-21,SERPINA5,and SPINT2via cAMPMatriptase-2,kallikrein-21,SERPINA5,and SPINT2were decreased in hCG-treated cells after a kinetics different from that described for uPA and uPAR (Fig.4A),and noeffectsF IG .1.RT-PCR analysis of various serine proteinases and SERPINs in 1-,3-,8-wk-old mice testes;germ cells either from total germinal cells (total)or fractions enriched in pachytene spermatocytes (scytes)or early spermatids (stids);mLTC-1cells;Leydig-enriched fractions recovered from 3-and 8-wk-old mice testes;or Sertoli cells recovered from 3-wk-old mice testes (SC 3-wk),which had been cultured for 2d in basal conditions.The set of primers used is listed in Table 2.RT-PCR studies were also conducted using primers directed against 18S to ensure that equal amounts of material were used.A DNA ladder was included in each gel for accurate determination of the size of the PCR product (not shown).Mat.-2,Matriptase-2;kall.-21,kal-likrein-21.F IG .2.Regulation of StAR,uPA,kallikrein-21,matriptase-2,SPINT2,and SERPINA5in the mLTC-1cells by hCG.Cells were cultured for 6h in the absence or presence of three different doses of hCG (1,10,and 100ng/ml,respectively).Three experiments were performed and a representative autoradiograph is shown.HPRT was used as a control in the RT-PCR studies.Odet et al.•Serine Proteinases,Serpins,and Mouse Testis Endocrinology,September 2006,147(9):4374–43834377were observed after 2h of stimulation.However,in cells treated for 8h with hCG,matriptase-2,kallikrein-21,SERPINA5,and SPINT2were significantly decreased (P Ͻ0.05),and their levels represented 33,40,36,and 50%of their respective control.After 24h of hCG exposure,the inhibition was stronger than that after 8h (except for SPINT2),with levels of matriptase-2,kallikrein-21,and SERPINA5de-creased to baseline levels.The kinetics of the effects induced by hCG were mimicked by the addition of bu 2cAMP,indi-cating the involvement of the protein kinase A (Fig.4).To determine the reversibility of the hCG-induced inhi-bition,mLTC-1cells were treated for 16h with hCG 100ng/ml,after which cells were washed and fresh culture me-dium was added.After 24h,cells were scraped and total RNA was extracted for RT-PCR studies.A densitometry analysis indicated a full recovery of the expression levels of matriptase-2and kallikrein-21,whereas the expression levels of SERPINA5and SPINT2had only partially recovered (Fig.4B).After 48h,half and full recovery of the expression levels of SERPINA5and SPINT2were observed,respectively (not shown).By Western blotting,a single protein,comigrating at 46kDa with proteins extracted from seminal vesicles rich in PCI (24),was detected in testis extracts as well as the culture media of mLTC-1.Addition of hCG 100ng/ml or bu 2cAMP 1m m for 24h resulted in a strong decrease in the 46-kDa migrating band corresponding to PCI (Fig.4C).Testosterone did not influence the expression of proteases and SERPINs in the mLTC-1cellsWe also investigated a possible influence of testosterone 0.1m added for 2,8,or 24h.Androgen receptors werefirst evidenced by RT-PCR (not shown).No effects of tes-tosterone were observed on uPA,matriptase-2,kallikrein-21,SERPINA5,or SPINT2(not shown).Gonadotropins regulate serine proteases and SERPINs expressed in primary culturesBecause mLTC-1cells were tumor cells,we wished to examine whether hCG and testosterone could regulate serine proteases and SERPINs expressed in normal Leydig cells.For this purpose,enriched fractions of Leydig cells were isolated from 3-and 8-wk-old mouse testes,cultured for 2d,and stimulated with hCG 100ng/ml or testosterone 0.1m for 2,24,or 48h (Fig.5).Androgen receptors were first evidenced by RT-PCR (not shown).The serine proteases and SERPINs examined include uPA,kallikrein-21,SERPINA5,SPINT2,and SERPINB2.tPA was also studied using the 8-wk-old preparations,but levels in the culture were too weak to be quantified (not shown).The data presented indicate that hCG significantly enhanced uPA and SERPINB2and that kallikrein-21,SERPINA5,and SPINT2were down-regulated by hCG in both types of primary cultures,i.e.from the 3-and 8-wk-old preparations (Fig.5).After 2h of stimulation,fold increases of uPA were 2.5and 4.9(P Ͻ0.05),respectively for the 3-and 8-wk-old preparations in primary cultures.No effects of hCG were observed in long-term cultures (24or 48h)(Fig.5A).The addition of hCG significantly increased SERPINB2levels after 24h of stimulation (a 4.1-fold increase;P Ͻ0.05),using the 8-wk-old preparations.The fold increase was 1.6(P Ͻ0.05)after 48h of stimulation using the 3-wk-old preparations.No significant effects were observed when the cells were treated for 2h with hCG (Fig.5A).The effects induced by hCG in primary cultures from the 8-wk-oldprep-F IG .3.Effects of hCG and bu 2cAMP on the expression levels of StAR,uPA,uPAR (RT-PCR),and uPA biological ac-tivity (plasminogen zymography)in mLTC-1cells.A,mLTC-1cells were stimulated for 2,8,or 24h in the pres-ence of hCG 100ng/ml or bu 2cAMP 1m M .C,Control,i.e.untreated cells.B,mLTC-1cells were pretreated for 30min with actinomycin D (Act)or cyclohexi-mide (CHX)and stimulated with hCG for 6h.Representative autoradiographs are shown in A and B.Autoradiographs were scanned and the expression was normal-ized to the HPRT signal.Values are the mean ϮSEM of n ϭ3;*,P Ͻ0.05,com-pared with untreated dishes.C,Zymo-graphic analysis of the culture media of mLTC-1cells stimulated for 24h in the presence or absence of 100ng/ml hCG or bu 2cAMP 1m M .A representative zymo-gram of four experiments performed is shown.The uPA lytic band is noted on the left.Cont,Control.4378Endocrinology,September 2006,147(9):4374–4383Odet et al.•Serine Proteinases,Serpins,and Mouse Testisarations were mimicked by bu 2cAMP (not shown).Primary cultures from the 3-wk-old preparations were not examined.The expression levels of kallikrein-21,SERPINA5,and SPINT2were not modified by a 2-h exposure with hCG or testosterone (not shown).However,their levels were signif-icantly (P Ͻ0.05)halved in primary cultures treated for 24or 48h with hCG (Fig.5B)or bu 2cAMP (not shown).Tes-tosterone had no effect (Fig.5B).Effects of the exogenous addition of protease inhibitors or of trypsinWe explored the hypothesis that the enhancement of uPA and StAR may be interdependent events.For this purpose,we carefully examined the kinetics of the hCG-induced stim-ulatory effects during the first hours of treatment to deter-mine which of uPA or StAR was first induced by hCG.Our data show that the hCG-induced enhancement of StAR and uPA followed closely the same pattern of expression up to 4h of stimulation,after which uPA levels decreased,whereas StAR levels were maintained at a significantly higher level than in the controls,in mLTC-1cells (Fig.6A).We also examined SERPINB2expression levels in the hCG-stimu-lated mLTC-1cells.We observed the appearance of a PCR product in the hCG-treated mLTC-1cells,whereas no PCR product was detected in untreated cells.However,the signal was too weak to be quantified (not shown).The expression levels of StAR were also significantly increased in primary cultures after a 2-h treatment with hCG (Fig.6B).We then explored whether the hCG-induced early peak of StAR could be mimicked by the addition of serine proteases.If so,the addition of serine protease inhibitors would de-crease the hCG-induced increase of StAR.Cells were there-fore pretreated with protease inhibitors or trypsin and then exposed to hCG for 2h and the expression of StAR was examined.The addition of serine protease inhibitors (in both normal and tumor cells)or trypsin 1,100,or 1000ng/ml (performed in the mLTC-1cells)had no effect on the hCG-or bu 2cAMP-induced StAR (Fig.6,B and C).Higher doses of trypsin resulted in cell detachment,and thus,their effect on StAR could not be examined (not shown).DiscussionIn the present study,we demonstrate that the mouse testis is the source of several serine proteinases and inhibitorsandF IG .4.Effects of hCG and bu 2cAMP on the expression levels of matriptase-2,kallikrein-21,SERPINA5,and SPINT2assessed by RT-PCR in mLTC-1cells.A,mLTC-1cells were stimulated for 2,8,or 24h with hCG 100ng/ml or bu 2cAMP 1m M .C,Control cells,i.e.untreated cells.Representative autoradiographs are shown.mLTC-1cells were cultured with (B)(ϩhCG)or without (C)hCG 100ng/ml for 16h.Cells were washed and fresh hCG-free medium was added for 24h.In A and B,autoradiographs were scanned and the expression was normalized to the HPRT signal (the same as in Fig.3for A).Values are the mean ϮSEM of n ϭ3.*,P Ͻ0.05,compared with untreated dishes in A and the time-matched controls in B.C,Western blot analysis of culture media of mLTC-1cells cultured for 24h with or without (C)100ng/ml hCG or bu 2cAMP 1m M (same culture media as in Fig.3C).Thirty micrograms of proteins were loaded per lane.Seminal vesicles (SV)and testis from adult mice (testis)were used as a positive control.The arrow points to the 46-kDa migrating band corresponding to SERPINA5.A representative gel of the three experiments performed is presented.Odet et al.•Serine Proteinases,Serpins,and Mouse Testis Endocrinology,September 2006,147(9):4374–43834379。